{
    "testId": 375624947,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 21,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 2,
    "testModeName": "Tutor",
    "questionModeId": 4,
    "questionModeName": "CUSTOM",
    "testName": "",
    "totalQuestionCorrect": 22,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 0,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 3849,
    "averageTimeSpentInSeconds": 128,
    "otherAverageTimeSpentInSeconds": 75,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 30,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "4",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 14848,
            "questionIndex": 16271,
            "questionText": "<p>A 2-week-old boy is brought to the office due to persistent yellowing of the skin and eyes.&nbsp; In the first few days of life, his parents were told the patient had jaundice that would likely improve over time.&nbsp; However, they feel that his color has not changed significantly.&nbsp; The patient was born at term, and his parents declined the hepatitis B vaccine because the mother&#39;s serologic studies confirm she&nbsp;is immune.&nbsp; The boy is exclusively breastfed and voids frequently.&nbsp; He has 3 or 4 bowel movements daily, and the stools are light yellow.&nbsp; The patient&#39;s only medication is vitamin D.&nbsp; Weight today is 3.5 kg (7.7 lb), increased from 3.4 kg (7.5 lb) at birth.&nbsp; Examination reveals scleral icterus and jaundice of the face and chest.&nbsp; The abdomen is soft with normal bowel sounds.&nbsp; The remainder of the examination is normal.&nbsp; Total bilirubin is 10.0 mg/dL and direct bilirubin is 7.4 mg/dL.&nbsp; Aspartate aminotransferase and alanine aminotransferase are within normal limits.&nbsp; Maternal blood type is O, Rh-D positive.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t51803\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Biliary atresia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Extrahepatic bile duct fibrosis &rarr; obstruction of bile (&amp;&nbsp;bilirubin) flow from liver to intestines</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />findings</strong></p></td><td><ul><li>Asymptomatic at birth</li><li>Infants age 2-8 weeks:<ul style=\"list-style-type:circle;\"><li>Jaundice, acholic stools, dark urine</li><li>Hepatomegaly</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic<br />evaluation</strong></p></td><td><ul><li>Direct hyperbilirubinemia</li><li>Ultrasonography:<ul style=\"list-style-type:circle;\"><li>Absent/abnormal gallbladder &amp;/or CBD</li></ul></li><li>Liver biopsy:<ul style=\"list-style-type:circle;\"><li>Intrahepatic bile duct proliferation</li><li>Portal tract inflammation &amp; edema</li><li>Fibrosis</li></ul></li><li>Intraoperative cholangiography (gold standard):<ul style=\"list-style-type:circle;\"><li>Biliary obstruction</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Surgical hepatoportoenterostomy (Kasai procedure)</li><li>Liver transplant</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CBD</strong> = common bile duct.</p></td></tr></tbody></table></div><p>This neonate has jaundice, light-colored stools, and direct hyperbilirubinemia, findings concerning for <strong>biliary atresia</strong> (BA), a rare but potentially fatal disease.&nbsp; BA is characterized by progressive fibrosis and obliteration of the <a href=\"2065\">extrahepatic bile ducts</a>.&nbsp; Bilirubin (bile pigment) continues to be conjugated by the liver but cannot be excreted by the biliary system, leading to cholestasis.</p><p>Symptoms typically manifest at <strong>age 2-8 weeks</strong> with <strong>jaundice</strong> and scleral icterus.&nbsp; <strong>Acholic stools</strong> (eg, light yellow, clay-colored, white) often occur because bile cannot reach the intestines, and urine may be dark yellow due to bilirubinuria.&nbsp; Laboratory evaluation reveals <strong>elevated direct bilirubin</strong>, often with normal or mildly elevated aspartate aminotransferase and alanine aminotransferase.</p><p>The next step in management of suspected BA is <strong>ultrasound of the right upper quadrant</strong> to assess biliary anatomy.&nbsp; Characteristic ultrasound findings include an abnormal/absent gallbladder, absent common bile duct, and triangular cord sign (fibrous remnants seen above the porta hepatis).</p><p>Liver biopsy is used to help distinguish BA from other cholestatic conditions (eg, Alagille syndrome) and typically reveals intrahepatic duct proliferation, portal tract edema, and fibrosis.&nbsp; Biliary obstruction on intraoperative cholangiography is the gold standard for diagnosis; if it is present, immediate hepatoportoenterostomy (Kasai procedure) is performed to reestablish bile flow to the small intestine.</p><p><strong>(Choice B)</strong>&nbsp; Hepatitis B vaccine and immunoglobulin are administered at birth to infants born to mothers who are hepatitis B surface antigen (HBsAg) positive; serial monitoring of HBsAg is then indicated.&nbsp; This patient&#39;s mother is immune and therefore HBsAg negative; despite not receiving the hepatitis B vaccine at birth, the patient is at low risk for infection and monitoring is not indicated.</p><p><strong>(Choice C)</strong>&nbsp; Continued breastfeeding is recommended for breast milk jaundice, which peaks at age 2 weeks and is characterized by increased enterohepatic circulation.&nbsp; This process is thought to be caused by elevated beta-glucuronidase in breast milk, leading to further deconjugation of bilirubin and therefore indirect (rather than direct) hyperbilirubinemia.</p><p><strong>(Choice D)</strong>&nbsp; Crigler-Najjar syndrome is an autosomal recessive disorder of bilirubin metabolism in which conjugation of bilirubin is decreased.&nbsp; Indirect hyperbilirubinemia would be expected.</p><p><strong>(Choice E)</strong>&nbsp; Supplementation with cow&#39;s milk&ndash;based formula may be required for some cases of breastfeeding failure jaundice in which breastfeeding newborns have inadequate intake and excessive weight loss, causing indirect hyperbilirubinemia in the first week of life.</p><p><strong>Educational objective:</strong><br>Biliary atresia is characterized by progressive fibrosis and obliteration of extrahepatic bile ducts.&nbsp; It typically presents at age 2-8 weeks with jaundice, acholic stools, and direct hyperbilirubinemia.&nbsp; Diagnostic evaluation of biliary anatomy begins with ultrasound of the right upper quadrant.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 22320,
            "topic": "Biliary atresia",
            "titleId": 22320,
            "title": "Biliary atresia",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Obtain ultrasound of right upper quadrant",
                    "choiceNumber": 1,
                    "correctTaken": 10173,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform serial monitoring of HBsAg",
                    "choiceNumber": 2,
                    "correctTaken": 661,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend continued breastfeeding only",
                    "choiceNumber": 3,
                    "correctTaken": 2510,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Send genetic testing for Crigler-Najjar syndrome",
                    "choiceNumber": 4,
                    "correctTaken": 1837,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Supplement with cow&#39;s milk&ndash;based formula",
                    "choiceNumber": 5,
                    "correctTaken": 1627,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "59,90,true,-1,1*372,533,true,-1,1*544,593,true,-1,1*1536,1570,true,-1,1*1640,1709,true,-1,1*1902,2121,true,-1,1*2531,2879,true,-1,1*3082,3338,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25658057",
                    "mediaDataId": 0,
                    "title": "Biliary atresia: clinical lessons learned.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25658057",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 177,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 16808,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1133,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 2917,
            "questionIndex": 2917,
            "questionText": "<p>A 45-year-old woman comes to the office due to cough with hemoptysis, night sweats, and subjective fever.&nbsp; A chest radiograph demonstrates right upper lobe cavity that is consistent with a diagnosis of pulmonary tuberculosis. Sputum staining for acid-fast bacteria is positive.&nbsp; She is begun on a regimen that includes isoniazid, rifampin, ethambutol, and pyrazinamide.&nbsp; The patient has a history of alcohol use disorder.&nbsp; She has taken oral contraceptive pills for the past 5 years.&nbsp; Two months later when she returns for follow-up examination, her sputum is clear of acid-fast bacilli.&nbsp; However, she now has fatigue, malaise, and nausea that began approximately 10 days ago.&nbsp; Physical examination reveals icteric sclerae and tender hepatomegaly.&nbsp; Laboratory results are as follows:</p><p>Liver studies</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"403\"><tbody><tr><td width=\"73%\">Albumin</td><td width=\"27%\">3.9 g/dL</td></tr><tr><td width=\"73%\">Total bilirubin</td><td width=\"27%\">4.8 mg/dL</td></tr><tr><td width=\"73%\">Alkaline phosphatase</td><td width=\"27%\">98 U/L</td></tr><tr><td width=\"73%\">Aspartate aminotransferase (SGOT)</td><td width=\"27%\">372 U/L</td></tr><tr><td width=\"73%\">Alanine aminotransferase (SGPT)</td><td width=\"27%\">410 U/L</td></tr></tbody></table></blockquote><p>Coagulation studies</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"403\"><tbody><tr><td width=\"73%\">Prothrombin time</td><td width=\"27%\">13 sec</td></tr><tr><td width=\"73%\">Partial thromboplastin time</td><td width=\"27%\">27 sec</td></tr></tbody></table></blockquote><p>Hepatitis panel</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"397\"><tbody><tr><td width=\"73%\">HBsAg</td><td width=\"27%\">Negative</td></tr><tr><td width=\"73%\">Anti-HBsAg</td><td width=\"27%\">Negative</td></tr><tr><td width=\"73%\">IgM Anti-HBcAg</td><td width=\"27%\">Negative</td></tr><tr><td width=\"73%\">HBeAg</td><td width=\"27%\">Negative</td></tr><tr><td width=\"73%\">Anti-HBeAg</td><td width=\"27%\">Negative</td></tr><tr><td width=\"73%\">Anti-HAV IgM</td><td width=\"27%\">Negative</td></tr><tr><td width=\"73%\">Anti-HAV IgG</td><td width=\"27%\">Negative</td></tr><tr><td width=\"73%\">Anti-HCV</td><td width=\"27%\">Negative</td></tr></tbody></table></blockquote><p>Liver biopsy demonstrates panlobular mononuclear infiltration and hepatic cell necrosis.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s liver function tests and liver biopsy result are consistent with a diagnosis of <strong>acute hepatitis</strong>.&nbsp; However, the negative viral serology results indicate an infectious cause of her hepatitis is unlikely.&nbsp; Since this patient is on <strong>isoniazid</strong>, idiosyncratic liver injury with a histological picture similar to viral hepatitis must be considered.&nbsp; Although extrahepatic hypersensitivity manifestations like rash, arthralgias, fever, leukocytosis, and eosinophilia are common in patients with <strong>drug-induced liver injury</strong>, they are characteristically absent in cases of isoniazid-induced hepatic cell injury.</p><p>Drugs and toxins typically cause hepatic injury, either through direct toxic effects or through idiosyncratic reactions.&nbsp; The direct toxic effects are dose-dependent and have short latent periods.&nbsp; Examples of direct toxins include acetaminophen and substances found in the <i>Amanita phalloides</i> mushroom.&nbsp; <strong>Idiosyncratic reactions</strong> are not dose-dependent and have variable latent periods.&nbsp; Some examples of pharmacological agents that cause idiosyncratic reactions include isoniazid, chlorpromazine, and antiretroviral therapy.</p><p>Drug-induced liver disease can also be broadly categorized according to morphology:&nbsp; cholestasis (eg, anabolic steroids), fatty liver (eg, valproate), hepatitis (as in this patient), toxic or fulminant liver (eg, acetaminophen), or granulomatous (eg, allopurinol).</p><p><b>(Choice A)</b>&nbsp; The patient&#39;s&nbsp;laboratory profile is not suggestive of alcoholic hepatitis. Classically, the AST:ALT ratio is &gt;2 in alcoholic hepatitis.&nbsp; Moreover, the timeline correlation between the initiation of treatment for tuberculosis and the onset of her hepatic dysfunction mandates close scrutiny of her pharmacotherapy regimen.</p><p><b>(Choice B)</b>&nbsp; Oral contraceptives are unusual in that they can cause abnormalities in liver function tests without evidence of necrosis or fatty change.&nbsp; As this patient&#39;s liver biopsy demonstrated necrosis, oral contraceptives are not likely responsible for her hepatic dysfunction.</p><p><b>(Choice D)&nbsp;&nbsp;</b>Autoimmune hepatitis should be considered once all possible causes of drug-induced or viral hepatitis have been ruled out.&nbsp; Positive antinuclear antibody (ANA) and/or positive smooth muscle antibody suggest the diagnosis of classic (type 1) autoimmune hepatitis.<b> </b></p><p><b>(Choice E)&nbsp;&nbsp;</b>Tuberculous hepatitis may develop in cases of miliary tuberculosis but would be characterized by granulomas on liver biopsy.&nbsp; Moreover, since this patient had a sputum conversion, it is highly unlikely that she is now suffering from miliary tuberculosis.</p><p><b>Educational objective:</b><br>Isoniazid causes idiosyncratic liver injury with histological features similar to those seen in patients with viral hepatitis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 23660,
            "topic": "Drug induced liver injury",
            "titleId": 23660,
            "title": "Drug induced liver injury",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute alcoholic hepatitis",
                    "choiceNumber": 1,
                    "correctTaken": 260,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatitis secondary to oral contraceptive usage",
                    "choiceNumber": 2,
                    "correctTaken": 170,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatitis secondary to isoniazid usage",
                    "choiceNumber": 3,
                    "correctTaken": 9297,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Autoimmune hepatitis",
                    "choiceNumber": 4,
                    "correctTaken": 1114,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tuberculous hepatitis",
                    "choiceNumber": 5,
                    "correctTaken": 753,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "386,643,true,-1,1*644,1167,true,-1,1*1168,1432,true,-1,1*2185,2321,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": true,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 235,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 11594,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 719,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 14865,
            "questionIndex": 16288,
            "questionText": "<p>A 4-week-old boy is brought to the clinic due to a change in bowel pattern.&nbsp; The patient was born at term and has been having a bowel movement after most feeds since birth.&nbsp; However, over the past week he has been stooling only 1 or 2 times a day, and the color has become consistently paler.&nbsp; The parents have also noticed progressive yellowing of the eyes over the last few weeks.&nbsp; The patient is exclusively breastfed and is in the 25th percentile for weight.&nbsp; He takes no medications.&nbsp; Temperature is 37.1 C (98.8 F).&nbsp; Physical examination shows a well-appearing infant with scleral icterus and jaundice of the face and chest.&nbsp; The abdomen is soft and bowel sounds are present.&nbsp; The liver is enlarged.&nbsp; The remainder of the examination is normal.&nbsp; Total bilirubin is 12.5 mg/dL.&nbsp; Hepatic ultrasound reveals absence of the gallbladder and confirms hepatomegaly.&nbsp; Which of the following laboratory patterns is most likely to be present in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t51803\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Biliary atresia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Extrahepatic bile duct fibrosis &rarr; obstruction of bile (&amp;&nbsp;bilirubin) flow from liver to intestines</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />findings</strong></p></td><td><ul><li>Asymptomatic at birth</li><li>Infants age 2-8 weeks:<ul style=\"list-style-type:circle;\"><li>Jaundice, acholic stools, dark urine</li><li>Hepatomegaly</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic<br />evaluation</strong></p></td><td><ul><li>Direct hyperbilirubinemia</li><li>Ultrasonography:<ul style=\"list-style-type:circle;\"><li>Absent/abnormal gallbladder &amp;/or CBD</li></ul></li><li>Liver biopsy:<ul style=\"list-style-type:circle;\"><li>Intrahepatic bile duct proliferation</li><li>Portal tract inflammation &amp; edema</li><li>Fibrosis</li></ul></li><li>Intraoperative cholangiography (gold standard):<ul style=\"list-style-type:circle;\"><li>Biliary obstruction</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Surgical hepatoportoenterostomy (Kasai procedure)</li><li>Liver transplant</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CBD</strong> = common bile duct.</p></td></tr></tbody></table></div><p>This infant has findings concerning for <strong>biliary atresia</strong>, a neonatal disorder characterized by progressive fibrosis and obliteration of <a href=\"2065\">extrahepatic bile ducts</a>.&nbsp; Conjugated bilirubin is produced by hepatocytes but cannot be transported through the fibrotic ducts, leading to cholestasis.&nbsp; Affected infants usually develop <strong>jaundice</strong> and <strong>hepatomegaly</strong> at age 2-8 weeks.&nbsp; Decreased bile excretion into the intestines also leads to <strong>acholic stools</strong> (eg, pale, clay-colored).&nbsp; Untreated disease can lead to splenomegaly due to progressive cirrhosis and portal hypertension.</p><p>Laboratory evaluation reveals <strong>elevated total</strong> and <strong>direct bilirubin</strong> levels.&nbsp; Bile duct destruction leads to <strong>elevated gamma-glutamyl transpeptidase</strong> (GGT) and alkaline phosphatase; aminotransferases are usually normal or mildly elevated.&nbsp; <strong>Reticulocyte count</strong> is <strong>normal</strong> due to the absence of hemolysis.</p><p>Abdominal ultrasound may reveal the triangular cord sign (fibrous remnants above the porta hepatis) or a small or <strong>absent gallbladder</strong>, findings highly suggestive of biliary atresia.&nbsp; Definitive diagnosis requires intraoperative cholangiography or liver biopsy.</p><p>If biliary atresia is confirmed, hepatoportoenterostomy (Kasai procedure) is performed to reestablish bile flow to the small intestine.&nbsp; However, most children with biliary atresia eventually require a liver transplant.</p><p><strong>(Choice B)</strong>&nbsp; Hemophagocytic lymphohistiocytosis (HLH) is a systemic inflammatory condition that can present with elevated direct bilirubin and GGT (due to cholestasis) and with cytopenias and decreased reticulocytes (due to bone marrow failure).&nbsp; In contrast to this patient, infants with HLH have a normal gallbladder and are typically febrile and ill-appearing.</p><p><strong>(Choice C)</strong>&nbsp; Certain rare, genetic causes of cholestasis, such as progressive familial intrahepatic cholestasis, cause direct hyperbilirubinemia with paradoxically normal GGT.&nbsp; Although the presentation is similar to biliary atresia (eg, jaundice, acholic stools), absence of the gallbladder is highly suggestive of biliary atresia.</p><p><strong>(Choice D)</strong>&nbsp; An elevated reticulocyte count in a child with jaundice and normal direct bilirubin suggests hemolysis.&nbsp; However, this patient&#39;s acholic stools and absent gallbladder make biliary atresia more likely.</p><p><strong>(Choice E)</strong>&nbsp; Breast milk jaundice is likely due to high levels of beta-glucuronidase in breast milk, which deconjugates intestinal bilirubin and increases enterohepatic circulation.&nbsp; Affected infants have indirect (not direct) hyperbilirubinemia and normal GGT.&nbsp; Unlike in this case, breast milk jaundice peaks at 2 weeks of life and is not associated with pale stools or an absent gallbladder.</p><p><strong>Educational objective:</strong><br>Biliary atresia is a neonatal disorder in which extrahepatic bile ducts develop progressive fibrosis.&nbsp; Patients have jaundice, pale stools, and a small or absent gallbladder.&nbsp; Laboratory findings include direct hyperbilirubinemia, normal reticulocyte count, and elevated gamma-glutamyl transpeptidase.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 22320,
            "topic": "Biliary atresia",
            "titleId": 22320,
            "title": "Biliary atresia",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "1",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"420px\"><tbody><tr style=\"text-align:center;\"><td width=\"33%\">&#8593;</td><td width=\"33%\">&#8593;</td><td width=\"33%\">Normal</td></tr></tbody></table>",
                    "choiceNumber": 1,
                    "correctTaken": 9823,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"420px\"><tbody><tr style=\"text-align:center;\"><td width=\"33%\">&#8593;</td><td width=\"33%\">&#8593;</td><td width=\"33%\">&#8595;</td></tr></tbody></table>",
                    "choiceNumber": 2,
                    "correctTaken": 1231,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"420px\"><tbody><tr style=\"text-align:center;\"><td width=\"33%\">&#8593;</td><td width=\"33%\">Normal</td><td width=\"33%\">Normal</td></tr></tbody></table>",
                    "choiceNumber": 3,
                    "correctTaken": 4395,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"420px\"><tbody><tr style=\"text-align:center;\"><td width=\"33%\">Normal</td><td width=\"33%\">Normal</td><td width=\"33%\">&#8593;</td></tr></tbody></table>",
                    "choiceNumber": 4,
                    "correctTaken": 883,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"420px\"><tbody><tr style=\"text-align:center;\"><td width=\"33%\">Normal</td><td width=\"33%\">Normal</td><td width=\"33%\">Normal</td></tr></tbody></table>",
                    "choiceNumber": 5,
                    "correctTaken": 633,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1101,1198,true,-1,1*1274,1433,true,-1,1*1678,1755,true,-1,1*1987,2338,true,-1,1*2350,2670,true,-1,1*3167,3213,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31455583",
                    "mediaDataId": 0,
                    "title": "A practical approach to the pathology of neonatal cholestatic liver disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31455583",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25658057",
                    "mediaDataId": 0,
                    "title": "Biliary atresia: clinical lessons learned.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25658057",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 77,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 16965,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"420px\"><tbody><tr style=\"text-align:center;\"><td width=\"33%\"><strong>Direct bilirubin</strong></td><td width=\"33%\"><strong>Gamma-glutamyl transpeptidase</strong></td><td width=\"33%\"><strong>Reticulocyte count</strong></td></tr></tbody></table>",
            "standards": null,
            "totalTimeSpentReview": 1076,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 2920,
            "questionIndex": 2920,
            "questionText": "<p>A 42-year-old man comes to the office due to persistent fatigue over the past 3 months.&nbsp; The patient has ulcerative colitis that was diagnosed 2 years ago.&nbsp; Treatment with mesalamine has adequately controlled the abdominal pain and diarrhea.&nbsp; Colonoscopy 6 months ago revealed improvement in colitis and other findings.&nbsp; Today the patient says he has &#x22;extreme&#x22; fatigue; he has had to take time off work several times because he is so tired.&nbsp; He reports no weight loss or other systemic symptoms.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 134/80 mm Hg, pulse is 74/min, and respirations are 15/min.&nbsp; No abdominal tenderness or organomegaly is present on physical examination.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Hemoglobin</td><td style=\"vertical-align:middle;\">11.8 g/dL</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Mean corpuscular volume</td><td style=\"vertical-align:middle;\">86 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Platelets</td><td style=\"vertical-align:middle;\">320,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Leukocytes</td><td style=\"vertical-align:middle;\">7,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Sodium</td><td style=\"vertical-align:middle;\">136 mEq/L</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Potassium</td><td style=\"vertical-align:middle;\">4.4 mEq/L</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Creatinine</td><td style=\"vertical-align:middle;\">0.6 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Albumin</td><td style=\"vertical-align:middle;\">3.8 g/dL</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Total bilirubin</td><td style=\"vertical-align:middle;\">1.7 mg/dL</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Alkaline phosphatase</td><td style=\"vertical-align:middle;\">816 U/L</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">45 U/L</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">54 U/L</td></tr></tbody></table><p>Which of the following is the best next step in diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T55618\" style=\"overflow-x:auto;\" tid=\"5065\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Primary sclerosing cholangitis</strong></p></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Clinical features</strong></p></td><td><ul><li>Asymptomatic initially; fatigue &amp; pruritus with progressive disease</li><li>Associated with IBD, particularly ulcerative colitis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory &amp; imaging results</strong></p></td><td><ul><li>Cholestasis (&#8593; ALP, GGT, bilirubin)</li><li>Multifocal strictures/dilation of bile ducts on MRCP</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Complications</strong></p></td><td><ul><li>Cholangitis, cholangiocarcinoma, colon cancer</li><li>Fat-soluble vitamin deficiencies</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALP</strong> = alkaline phosphatase; <strong>GGT</strong> = &#947;-glutamyl transferase; <strong>IBD</strong> = inflammatory bowel disease; <strong>MRCP</strong> = MR cholangiopancreatography.</p></td></tr></tbody></table></div><p>This patient has a cholestatic pattern of laboratory abnormalities, including <strong>elevated alkaline phosphatase</strong> and <strong>total bilirubin</strong>.&nbsp; In a patient with a history of <strong>ulcerative colitis (UC)</strong> and new cholestasis, <strong>primary sclerosing cholangitis (PSC)</strong> should be ruled out.&nbsp; PSC is a chronic progressive disorder characterized by inflammation, fibrosis, and stricturing of intrahepatic and extrahepatic bile ducts.&nbsp; Nearly 90% of patients with PSC have underlying UC.&nbsp; Patients are commonly asymptomatic at presentation or have <strong>fatigue</strong> (often severe) and/or pruritus.&nbsp; This patient&#39;s mildly abnormal transaminase levels most likely reflect mild hepatic dysfunction secondary to cholestasis.</p><p>In patients with a higher pretest probability of PSC, <strong>magnetic resonance cholangiopancreatography</strong> (MRCP) is recommended early in the diagnostic work-up because it is noninvasive and has high sensitivity for visualizing the biliary tree.&nbsp; Characteristic findings of intra- and extrahepatic segmental bile duct <a href=\"78163\">strictures and dilation</a> are diagnostic of PSC.&nbsp; Abdominal ultrasonography is often performed before MRCP to evaluate for other common causes of cholestasis (eg, choledocholithiasis), but it has inferior diagnostic sensitivity for biliary disorders.</p><p><strong>(Choices A and F)</strong>&nbsp; Antimitochondrial antibody assay and liver biopsy are used to diagnose primary biliary cholangitis, which presents with cholestasis due to autoimmune intrahepatic bile duct destruction.&nbsp; It primarily occurs in women and is not associated with UC.</p><p><strong>(Choice B)</strong>&nbsp; Biliary scintigraphy (HIDA scan) uses a radioactive tracer to follow biliary drainage.&nbsp; It is used predominantly to diagnose acute cholecystitis (ie, absent gallbladder tracer uptake due to cystic duct stone) when ultrasonography findings are equivocal.&nbsp; Although a HIDA scan can provide a crude visualization of the biliary ducts, it is not sensitive or specific enough to diagnose PSC.</p><p><strong>(Choice C)</strong>&nbsp; Carcinoembryonic antigen levels are elevated in colon cancer, which can metastasize to the liver and cause cholestasis.&nbsp; Although UC increases colon cancer risk, metastatic colon cancer is unlikely in this patient whose colonoscopy from 6 months ago did not reveal colon cancer.</p><p><strong>(Choice D)</strong>&nbsp; CT scan of the abdomen with oral contrast is primarily useful for assessing the gastrointestinal lumen (eg, suspected bowel perforation).&nbsp; Intravenous (not oral) contrast is preferred when evaluating malignant lesions (eg, pancreatic cancer, cholangiocarcinoma) as a cause of cholestasis.&nbsp; Moreover, malignancy is less likely in this young patient with no history of smoking, weight loss, or systemic symptoms; and MRCP is preferred over CT scan when biliary disease is suspected.</p><p><strong>Educational objective:</strong><br>Patients with ulcerative colitis and cholestatic laboratory abnormalities should be assessed for primary sclerosing cholangitis.&nbsp; MR cholangiopancreatography is the preferred test; findings of segmental biliary strictures confirm the diagnosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 20379,
            "topic": "Primary Sclerosing Cholangitis",
            "titleId": 20379,
            "title": "Primary Sclerosing Cholangitis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antimitochondrial antibody assay",
                    "choiceNumber": 1,
                    "correctTaken": 1119,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Biliary scintigraphy (HIDA)",
                    "choiceNumber": 2,
                    "correctTaken": 836,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Carcinoembryonic antigen level",
                    "choiceNumber": 3,
                    "correctTaken": 183,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the abdomen with oral contrast",
                    "choiceNumber": 4,
                    "correctTaken": 705,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MR cholangiopancreatography",
                    "choiceNumber": 5,
                    "correctTaken": 2016,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Percutaneous liver biopsy",
                    "choiceNumber": 6,
                    "correctTaken": 158,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "332,410,true,-1,1*2747,3036,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "419",
                    "mediaDataId": 0,
                    "title": "Primary sclerosing cholangitis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33377990",
                    "mediaDataId": 0,
                    "title": "Management of primary sclerosing cholangitis and its complications: an algorithmic approach.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33377990",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 105,
            "othersAvgTimeSpent": 110,
            "notes": null,
            "peopleTaken": 5017,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 40,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1345,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 2217,
            "questionIndex": 2217,
            "questionText": "<p>A 56-year-old man is brought to the emergency department with nonbloody diarrhea, progressive lethargy, and confusion for the past 2 days.&nbsp; The patient has a history of cirrhosis due to chronic alcohol use.&nbsp; Medications include spironolactone and furosemide.&nbsp; Temperature is 37.8 C (100 F), blood pressure is 114/66 mm Hg, pulse is 110/min, and respirations are 24/min.&nbsp; The lungs are clear to auscultation and heart sounds are normal.&nbsp; Abdominal examination reveals distension with shifting dullness and mild tenderness to palpation in all four quadrants.&nbsp; There is bilateral pitting edema of the lower extremities.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td style=\"padding-left: 2em;\">Hemoglobin</td><td>11.8 g/dL</td></tr><tr><td style=\"padding-left: 2em;\">Platelets</td><td>110,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em;\">Leukocytes</td><td>12,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td style=\"padding-left: 2em;\">Sodium</td><td>130 mEq/L</td></tr><tr><td style=\"padding-left: 2em;\">Potassium</td><td>4.6 mEq/L</td></tr><tr><td style=\"padding-left: 2em;\">Bicarbonate</td><td>22 mEq/L</td></tr><tr><td style=\"padding-left: 2em;\">Blood urea nitrogen</td><td>20 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Creatinine</td><td>1.0 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Glucose</td><td>92 mg/dL</td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td style=\"padding-left: 2em;\">Albumin</td><td>2.1 g/dL</td></tr><tr><td style=\"padding-left: 2em;\">Total bilirubin</td><td>2.5 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Alkaline phosphatase</td><td>70 U/L</td></tr><tr><td style=\"padding-left: 2em;\">Aspartate aminotransferase (SGOT)</td><td>66 U/L</td></tr><tr><td style=\"padding-left: 2em;\">Alanine aminotransferase (SGPT)</td><td>42 U/L</td></tr></tbody></table><p>Urinalysis is normal.&nbsp; Which of the following would best establish the diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T34844\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Spontaneous bacterial peritonitis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Ranging from asymptomatic to severe infection</li><li>Classic: fever, abdominal pain, altered mental status</li></ul></td></tr><tr><td><p align=\"center\"><strong>Ascitic fluid findings</strong></p></td><td><ul><li>Cell count and differential: neutrophils &#8805;250/mm<sup>3</sup></li><li>Culture: <em>Escherichia coli</em> &amp; <em>Klebsiella</em> (50%); streptococci&nbsp; &nbsp;</li><li>Protein: &lt;1 g/dL</li><li>SAAG: &gt;1.1 g/dL (reflecting portal hypertension)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Empiric third-generation cephalosporin</li><li>Antibiotic prophylaxis: prior SBP (secondary prevention) &amp; upper GI bleeding (primary prevention)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>GI</strong> = gastrointestinal; <strong>SAAG</strong> = serum-ascites albumin gradient; <strong>SBP</strong> = spontaneous bacterial peritonitis.</p></td></tr></tbody></table></div><p>This patient with <strong>ascites</strong> (due to cirrhosis) has abdominal tenderness and altered mental status (AMS), suggesting <strong>spontaneous bacterial peritonitis (SBP)</strong>.&nbsp; SBP is characterized by infection of <strong>abdominal ascitic fluid</strong> due to translocation (eg, during gastrointestinal illness) of enteric bacteria such as <em>Escherichia coli</em> or, less commonly, hematogenous spread.&nbsp; Patients may be asymptomatic or show signs of infection ranging from mild (eg, low-grade fever, minimal leukocytosis) to severe (eg, septic shock).&nbsp; AMS is common and often accompanied by altered gastrointestinal motility (eg, vomiting, diarrhea, ileus).</p><p>Because the presentation of SBP can be subtle, there should be a low threshold for <strong>diagnostic paracentesis</strong> with fluid analysis in patients with ascites.&nbsp; <strong>Cell count and differential</strong> analysis is the <strong>most sensitive</strong> test for SBP.&nbsp; An ascitic <strong>neutrophil count &#8805;250/mm</strong><font size=\"2\"><sup><strong>3</strong></sup></font> is diagnostic and warrants empiric intravenous antibiotics (eg, third-generation cephalosporin).&nbsp; Although ascitic culture and Gram stain are also collected, these tests are not as helpful for diagnosis given their lower sensitivity (ie, positive cultures in only 40%-60% of cases) <strong>(Choice E)</strong>.&nbsp; However, positive ascitic cultures are useful for narrowing antibiotic coverage.</p><p><strong>(Choice A)</strong>&nbsp; Arterial blood gas analysis can identify AMS caused by symptomatic hypercapnia, which can be seen in exacerbations of obstructive lung disease or severe respiratory depression.&nbsp; However, this patient has no history of pulmonary disease, and the absence of both wheezing and hypoventilation makes hypercapnia unlikely.</p><p><strong>(Choice B)</strong>&nbsp; Blood cultures can occasionally identify the causative organism in SBP but have much lower sensitivity than cell count and differential.&nbsp; This limitation occurs because certain organisms are difficult to culture and most cases are due to bacterial translocation.</p><p><strong>(Choice D)</strong>&nbsp; Abdominal CT scan can be obtained on suspicion for secondary bacterial peritonitis due to an intraabdominal source other than translocation (eg, bowel perforation, perinephric abscess).&nbsp; This patient lacks abdominal rigidity, rebound tenderness, or any obvious manifestations of another intraabdominal process (eg, normal urinalysis).</p><p><strong>(Choice F)</strong>&nbsp; Ultrasonography of the hepatic veins is used to evaluate for hepatic venous outflow tract obstruction (eg, thrombosis) as seen in Budd-Chiari syndrome.&nbsp; Although abdominal tenderness, ascites, edema, and AMS can be seen, tenderness is typically in the right upper quadrant, and more significant liver function abnormalities would likely be seen (from hepatic congestion).</p><p><strong>Educational objective:</strong><br>Spontaneous bacterial peritonitis can have a subtle presentation and should be considered in patients with ascites accompanied by abdominal tenderness, altered mental status, or fever.&nbsp; The most sensitive tests are cell count and differential of ascites fluid (diagnosed if neutrophils &#8805;250/mm<font size=\"2\"><sup>3</sup></font>).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 19410,
            "topic": "Spontaneous bacterial peritonitis",
            "titleId": 19410,
            "title": "Spontaneous bacterial peritonitis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Arterial blood gas analysis",
                    "choiceNumber": 1,
                    "correctTaken": 686,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Blood culture",
                    "choiceNumber": 2,
                    "correctTaken": 284,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cell count and differential of abdominal fluid",
                    "choiceNumber": 3,
                    "correctTaken": 10945,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the abdomen",
                    "choiceNumber": 4,
                    "correctTaken": 887,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Culture and Gram stain results of abdominal fluid",
                    "choiceNumber": 5,
                    "correctTaken": 1392,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ultrasonography of the hepatic veins",
                    "choiceNumber": 6,
                    "correctTaken": 706,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "355",
                    "mediaDataId": 0,
                    "title": "Complications of cirrhosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30666172",
                    "mediaDataId": 0,
                    "title": "Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30666172",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 176,
            "othersAvgTimeSpent": 89,
            "notes": null,
            "peopleTaken": 14900,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1111,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 16408,
            "questionIndex": 17852,
            "questionText": "<p>A 47-year-old man comes to the office due to bloating and abdominal discomfort for the past 2 months.&nbsp; The patient&#39;s abdomen has become progressively enlarged in association with a 20-lb (9-kg) weight gain.&nbsp; He also notes fatigue and difficulty breathing while walking up and down steps but has not had chest pain or palpitations.&nbsp; The patient drinks 8-10 beers a day but does not use tobacco or recreational drugs.&nbsp; He has no prior medical history.&nbsp; Temperature is 37.5 C (99.5 F), blood pressure is 130/65 mm Hg, pulse is 75/min, and respirations are 15/min.&nbsp; Physical examination shows scleral icterus, palmar erythema, and multiple spider angiomas.&nbsp; The abdomen is distended and nontender, and a fluid wave is present.&nbsp; Right upper quadrant ultrasonography demonstrates a nodular, shrunken liver, as well as fluid in the intraperitoneal cavity.&nbsp; Diagnostic paracentesis reveals straw-yellow fluid.&nbsp; Which of the following fluid analysis tests should be performed?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34595\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Ascitic&nbsp;fluid characteristics</strong></p></td></tr><tr><td><p align=\"center\"><strong>Gross appearance</strong></p></td><td><ul><li>Typically straw-colored &amp; clear</li><li>Bloody: suggests trauma or malignancy</li><li>Cloudy: suggests infection</li><li>Milky: suggests lymphatic disruption (chylous)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Serum-to-ascites<br />albumin gradient (SAAG)</strong></p></td><td><ul><li>&ge;1.1 g/dL indicates portal HTN<ul style=\"list-style-type:circle;\"><li>Causes include cirrhosis, heart failure</li></ul></li><li>&lt;1.1 g/dL indicates no portal HTN<ul style=\"list-style-type:circle;\"><li>Causes include malignancy, TB, nephrotic syndrome</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Total protein</strong></p></td><td><ul><li>&lt;2.5 g/dL is consistent with cirrhosis or nephrotic syndrome</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cell count</strong></p></td><td><ul><li>&ge;250 neutrophils/mm<sup>3</sup> is diagnostic of SBP</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>HTN</strong>&nbsp;=&nbsp;hypertension; <strong>SBP</strong>&nbsp;=&nbsp;spontaneous bacterial peritonitis; <strong>TB</strong>&nbsp;=&nbsp;tuberculosis.</p></td></tr></tbody></table></div><p>This patient has developed abdominal distension, weight gain, and exertional dyspnea due to <strong>ascites</strong> (ie, fluid within the peritoneal cavity).&nbsp; Ascites can be due to portal hypertension (eg, cirrhosis, cardiac ascites) or non&shy;portal hypertensive causes (eg, malignancy, tuberculosis).&nbsp; Most cases (~85%) are caused by portal hypertension from <strong>cirrhosis</strong>, as suggested by this patient&#39;s stigmata of chronic liver disease (eg, palmar erythema, spider angiomas), heavy alcohol use, and abnormal ultrasonography (ie, shrunken, nodular liver).&nbsp; However, complete evaluation of new-onset ascites requires <strong>diagnostic paracentesis</strong> to confirm the suspected etiology.</p><p>Measurement of ascites <strong>albumin</strong> is used to calculate the <a href=\"66656\">serum-to-ascites albumin gradient (SAAG)</a>, which is elevated (&#8805;1.1 g/dL) in portal hypertension.&nbsp; The differential diagnosis of portal hypertensive ascites can further be narrowed by obtaining a <strong>total protein</strong> level; protein &lt;2.5 g/dL is consistent with cirrhosis, whereas protein &#8805;2.5 g/dL suggests right-sided heart failure (ie, hepatic congestion).</p><p><strong>Cell count and differential</strong> of ascitic fluid should also be obtained to assess for elevated leukocytes.&nbsp; Lymphocyte predominance indicates malignancy or tuberculosis; neutrophil predominance (ie, &#8805;250/mm<font size=\"2\"><sup>3</sup></font>) suggests spontaneous bacterial peritonitis, which occasionally presents with minimal or absent symptoms (eg, fever, abdominal pain, mental status changes).</p><p><strong>(Choice A)</strong>&nbsp; An ascitic bilirubin level can be elevated in the setting of a biliary or bowel perforation.&nbsp; Patients typically have brown ascites and severe abdominal pain with peritoneal signs (eg, guarding).</p><p><strong>(Choices C and E)</strong>&nbsp; Cytology should be performed if there is concern for malignancy (ie, peritoneal carcinomatosis), which would be suggested by low ascitic glucose, SAAG &lt;1.1 g/dL, and bloody ascites.&nbsp; Yellow ascitic fluid is more suggestive of benign ascites from cirrhosis (vs bloody fluid with malignancy).</p><p><strong>(Choices D and F)</strong>&nbsp; Fluid pH, lactate dehydrogenase (LDH), and protein levels are typically used during the evaluation of pleural effusions following diagnostic thoracentesis.&nbsp; LDH and protein levels distinguish between transudative and exudative effusions (<a href=\"4580\">Light criteria</a>), and low pH often reflects infection, malignancy, or rheumatoid arthritis.</p><p><strong>Educational objective:</strong><br>Evaluation of new-onset ascites includes diagnostic paracentesis for fluid analysis to help determine the etiology.&nbsp; Cell count and differential, albumin, and total protein levels are typically ordered.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 2802,
            "topic": "Ascites",
            "titleId": 2802,
            "title": "Ascites",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "2",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bilirubin",
                    "choiceNumber": 1,
                    "correctTaken": 1977,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cell count and differential",
                    "choiceNumber": 2,
                    "correctTaken": 9439,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cytology",
                    "choiceNumber": 3,
                    "correctTaken": 3280,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fluid pH",
                    "choiceNumber": 4,
                    "correctTaken": 742,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucose",
                    "choiceNumber": 5,
                    "correctTaken": 447,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lactate dehydrogenase",
                    "choiceNumber": 6,
                    "correctTaken": 4982,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "77,107,true,-1,1*262,416,true,-1,1*431,491,true,-1,1*1433,1686,true,-1,1*1792,1853,true,-1,1*1902,2048,true,-1,1*2060,2254,true,-1,1*2584,2594,true,-1,1*2844,2914,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "355",
                    "mediaDataId": 0,
                    "title": "Complications of cirrhosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "410",
                    "mediaDataId": 0,
                    "title": "Cirrhosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27762220",
                    "mediaDataId": 0,
                    "title": "The diagnostic work-up in patients with ascites: current guidelines and future prospects.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27762220",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 155,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 20867,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 45,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2604,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 2983,
            "questionIndex": 2983,
            "questionText": "<p>A 16-year-old boy is evaluated due to new-onset jaundice.&nbsp; The patient was admitted to the hospital 24 hours ago after an emergency appendectomy, as well as drainage and irrigation of the peritoneal cavity, due to a perforated appendicitis.&nbsp; He has no chronic medical conditions.&nbsp; Current medications are intravenous morphine and piperacillin-tazobactam.&nbsp; The patient has not received blood products.&nbsp; Temperature is 38.1 C (100.6 F), blood pressure is 118/80 mm Hg, and pulse is 98/min.&nbsp; On examination, there is mild scleral icterus.&nbsp; Cardiopulmonary examination is normal.&nbsp; The laparotomy site is mildly tender; there is no rigidity or rebound tenderness.&nbsp; No drain was placed.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td style=\"padding-left:2em\">Hemoglobin</td><td>14.4 g/dL</td></tr><tr><td style=\"padding-left:2em\">Platelets</td><td>260,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left:2em\">Leukocytes</td><td>11,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td style=\"padding-left:2em\">Total bilirubin</td><td>3.3 mg/dL</td></tr><tr><td style=\"padding-left:2em\">Direct bilirubin</td><td>0.3 mg/dL</td></tr><tr><td style=\"padding-left:2em\">Alkaline phosphatase</td><td>70 U/L</td></tr><tr><td style=\"padding-left:2em\">Aspartate aminotransferase (SGOT)</td><td>27 U/L</td></tr><tr><td style=\"padding-left:2em\">Alanine aminotransferase (SGPT)</td><td>24 U/L</td></tr></tbody></table><p>Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t69343\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Gilbert syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology</strong></p></td><td><ul><li>Most common inherited disorder of bilirubin metabolism</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>&#8595; Hepatic UDP glucuronosyltransferase activity &#8594; &#8595; conjugation of bilirubin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical findings</strong></p></td><td><ul><li>Recurrent episodes of mild jaundice</li><li>Provoked by stress (eg, febrile illness, fasting, dehydration, vigorous exercise, menstruation, surgery)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>&#8593; Unconjugated bilirubin (ie, indirect hyperbilirubinemia)</li><li>Normal CBC, blood smear, reticulocyte count</li><li>Normal AST, ALT, alkaline phosphatase</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Benign; no treatment required</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALT</strong> = alanine aminotransferase; <strong>AST</strong> = aspartate aminotransferase; <strong>CBC</strong> = complete blood count.</p></td></tr></tbody></table></div><p>This patient with mild scleral icterus following surgery has elevated indirect (unconjugated) bilirubin levels with otherwise normal liver function tests and no evidence of hemolysis (ie, normal hemoglobin).&nbsp; This presentation is consistent with <strong>Gilbert syndrome</strong>, a benign inherited disorder of bilirubin glucuronidation.</p><p>Gilbert syndrome is characterized by decreased activity of <a href=\"6598\">UDP glucuronosyltransferase</a>, the enzyme responsible for <a href=\"2675\">bilirubin conjugation</a> within the liver.&nbsp; This results in <strong>indirect hyperbilirubinemia</strong>, which is exacerbated by <strong>stressors</strong> such as febrile illness, fasting, vigorous exercise, and <strong>surgery</strong>.&nbsp; Physical examination is normal other than <strong>mild jaundice</strong> during an episode.&nbsp; Although Gilbert syndrome does not cause additional laboratory or examination findings, the underlying trigger may explain other presenting signs; for example, this patient&#39;s low-grade fever and mild leukocytosis are likely related to resolving appendicitis and peritonitis.</p><p>The diagnosis of Gilbert syndrome is confirmed by elevated levels of unconjugated bilirubin on repeat testing with normal liver function tests and complete blood count results.&nbsp; Patients should be reassured that the condition is benign and that no treatment is required.</p><p><strong>(Choice A)</strong>&nbsp; Ischemic injury to the gallbladder can cause acalculous cholecystitis in critically ill patients.&nbsp; Although fever and leukocytosis are common, most patients also have conjugated hyperbilirubinemia and mild elevations in alkaline phosphatase and aminotransaminases; an isolated unconjugated hyperbilirubinemia is atypical.</p><p><strong>(Choice B)</strong>&nbsp; Glucose-6-phosphate dehydrogenase deficiency can cause hemolytic anemia following red blood cell exposure to oxidative stress (eg, infection).&nbsp; Although unconjugated hyperbilirubinemia is typical, a low hemoglobin level should be present.</p><p><strong>(Choice D)</strong>&nbsp; Ischemic hepatopathy due to profound hypotension (eg, septic shock, blood loss) causes significantly elevated aminotransaminases (&gt;1,000 U/L) and, frequently, elevated conjugated bilirubin and alkaline phosphatase levels, none of which are seen in this patient.&nbsp; He is also hemodynamically stable, making this diagnosis unlikely.</p><p><strong>(Choice E)</strong>&nbsp; Iatrogenic biliary injury can manifest as a bile leak, causing fever, abdominal pain, and jaundice.&nbsp; Laboratory findings would include elevated aminotransaminases, alkaline phosphatase, and conjugated bilirubin.&nbsp; Moreover, this injury is typically associated with cholecystectomy, not appendectomy.</p><p><strong>(Choice F)</strong>&nbsp; Intraoperative use of inhaled halogenated anesthetics (eg, halothane) can cause hepatoxicity with significantly elevated aminotransaminase levels, which are not present in this patient.</p><p><strong>Educational objective:</strong><br>Gilbert syndrome, caused by decreased hepatic glucuronosyltransferase activity, is a benign disorder characterized by recurrent episodes of mild jaundice precipitated by stressors (eg, illness, surgery).&nbsp; Laboratory findings show an isolated unconjugated hyperbilirubinemia (ie, normal transaminases and complete blood count).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 1430,
            "topic": "Hereditary hyperbilirubinemias",
            "titleId": 1430,
            "title": "Hereditary hyperbilirubinemias",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acalculous cholecystitis",
                    "choiceNumber": 1,
                    "correctTaken": 261,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Deficiency of glucose-6-phosphate dehydrogenase",
                    "choiceNumber": 2,
                    "correctTaken": 835,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decrease in hepatic glucuronosyltransferase activity",
                    "choiceNumber": 3,
                    "correctTaken": 3376,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypoperfusion-induced liver injury",
                    "choiceNumber": 4,
                    "correctTaken": 105,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Iatrogenic biliary injury",
                    "choiceNumber": 5,
                    "correctTaken": 422,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Liver injury due to an inhaled anesthetic",
                    "choiceNumber": 6,
                    "correctTaken": 81,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "354,361,true,-1,1*1623,1893,true,-1,1*2437,2478,true,-1,1*2491,2752,true,-1,1*2833,3131,true,-1,1*3144,3329,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "609",
                    "mediaDataId": 0,
                    "title": "Hereditary hyperbilirubinemias",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22160004",
                    "mediaDataId": 0,
                    "title": "Gilbert syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22160004",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 167,
            "othersAvgTimeSpent": 106,
            "notes": null,
            "peopleTaken": 5080,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1646,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 2910,
            "questionIndex": 2910,
            "questionText": "<p>A 45-year-old woman comes to the office for follow-up of persistently abnormal liver function test results.&nbsp; The patient has a 3-year history of hypercholesterolemia treated with a statin medication.&nbsp; It was temporarily held 2 months ago when a moderate elevation in hepatic transaminases was noted.&nbsp; The patient has no jaundice, abdominal pain, or nausea.&nbsp; Medical history also includes type 2 diabetes mellitus, for which she takes metformin.&nbsp; The patient drinks 1-2 glasses of wine on weekends and does not use tobacco or recreational drugs.&nbsp; There is no family history of liver disease.&nbsp; Vital signs are normal.&nbsp; BMI is 36 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Mild hepatomegaly is noted on examination.&nbsp; Laboratory results today are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Albumin</td><td style=\"vertical-align:middle;\">4.0 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Total bilirubin</td><td style=\"vertical-align:middle;\">1.0 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Alkaline phosphatase</td><td style=\"vertical-align:middle;\">121 U/L</td></tr><tr><td style=\"vertical-align:middle;\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">82 U/L</td></tr><tr><td style=\"vertical-align:middle;\">Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">93 U/L</td></tr></tbody></table><p>Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36385\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Metabolic dysfunction-associated steatotic liver disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Hepatic steatosis on imaging or biopsy</li><li>Exclusion of other etiologies (eg, alcohol, hepatitis&nbsp;C, glucocorticoids)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Mostly asymptomatic</li><li>Metabolic syndrome*</li><li>AST/ALT ratio &lt;1</li><li>Ultrasonographic findings: &uarr; echogenicity (steatosis), coarse echotexture (fibrosis)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Weight loss (eg, diet modification, exercise)</li><li>Consider bariatric surgery if BMI &ge;35 kg/m<sup>2</sup></li></ul></td></tr><tr><td><p align=\"center\"><strong>Prognosis</strong></p></td><td><ul><li>Hepatic fibrosis associated with increased risk for cirrhosis &amp; liver-related death</li></ul></td></tr><tr><td colspan=\"2\"><p>*Obesity, diabetes mellitus, dyslipidemia, hypertension.</p><p><strong>ALT</strong> = alanine aminotransferase;<strong> AST</strong> = aspartate aminotransferase.</p></td></tr></tbody></table></div><p>This patient with persistent aminotransferase elevation and hepatomegaly has comorbid obesity, diabetes mellitus, and hyperlipidemia without a history of significant alcohol use.&nbsp; This presentation suggests <strong>nonalcoholic fatty liver disease</strong> (NAFLD), defined as <strong>hepatic steatosis</strong> in the absence of other causes of secondary hepatic fat accumulation (eg, alcohol).&nbsp; The incidence has risen with the increase in <strong>metabolic syndrome</strong>, with nearly half of patients with obesity demonstrating steatosis on liver biopsy.</p><p>Most patients with NAFLD have <strong>hepatomegaly</strong>, but stigmata of chronic liver disease (eg, jaundice, abdominal pain) are not typically seen unless cirrhosis develops.&nbsp; Liver markers typically show mild elevations in aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels; in many (but not all) cases, the AST/ALT ratio is &lt;1.&nbsp; Alkaline phosphatase levels may also be elevated; however, albumin and bilirubin levels are typically normal until cirrhosis develops.</p><p>Diagnosis is often made based on history, laboratory results, and imaging findings (eg, hyperechoic texture on ultrasound examination) but can be confirmed with liver biopsy if unclear.&nbsp; Management includes <strong>weight loss</strong> and control of metabolic risk factors (eg, hyperlipidemia).</p><p><strong>(Choice A)</strong>&nbsp; Autoimmune hepatitis causes marked elevation in AST and ALT (eg, hundreds to thousands) and bilirubin levels.&nbsp; It is often associated with arthralgia, anorexia, and fatigue.</p><p><strong>(Choice B)</strong>&nbsp; Hemochromatosis can cause transaminase elevation and diabetes, but it typically presents after menopause in women because menstruation slows iron accumulation.&nbsp; In addition, skin hyperpigmentation, arthralgia, and fatigue are common.</p><p><strong>(Choice D)</strong>&nbsp; Primary biliary cholangitis is characterized by destruction of the intrahepatic bile ducts, leading to cholestatic disease (ie, markedly elevated alkaline phosphatase levels), fatigue, and pruritus.</p><p><strong>(Choice E)</strong>&nbsp; Statin-induced liver injury typically causes mild transaminitis within the first 3 months of therapy (in contrast to this patient, who has taken a statin for several years).&nbsp; Moreover, this patient&#39;s transaminase level remains elevated even after holding the statin for 2 months, suggesting a different cause.&nbsp; Statins are considered safe in patients with NAFLD.</p><p><strong>Educational objective:</strong><br>Nonalcoholic fatty liver disease is characterized by hepatomegaly, with mild elevations in liver transaminase levels in the absence of other causes of secondary hepatic fat accumulation (eg, alcohol).&nbsp; It is most common in patients with metabolic syndrome.&nbsp; Management includes weight loss and control of metabolic risk factors.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 9995,
            "topic": "Nonalcoholic fatty liver disease",
            "titleId": 9995,
            "title": "Nonalcoholic fatty liver disease",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Autoimmune hepatitis",
                    "choiceNumber": 1,
                    "correctTaken": 711,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemochromatosis",
                    "choiceNumber": 2,
                    "correctTaken": 432,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonalcoholic fatty liver disease",
                    "choiceNumber": 3,
                    "correctTaken": 14382,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary biliary cholangitis",
                    "choiceNumber": 4,
                    "correctTaken": 2279,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Statin-induced liver injury",
                    "choiceNumber": 5,
                    "correctTaken": 2678,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "147,186,true,-1,1*244,260,true,-1,1*363,406,true,-1,1*814,929,true,-1,1*1471,1555,true,-1,1*1958,2019,true,-1,1*2098,2190,true,-1,1*2534,2591,true,-1,1*2801,2852,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "624",
                    "mediaDataId": 0,
                    "title": "Evaluation of abnormal liver function tests (LFTs)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "716",
                    "mediaDataId": 0,
                    "title": "Metabolic dysfunction-associated steatotic liver disease (MASLD) (formerly NAFLD)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26234727",
                    "mediaDataId": 0,
                    "title": "Nonalcoholic fatty liver disease and statins.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26234727",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30652643",
                    "mediaDataId": 0,
                    "title": "The role of statins in the management of nonalcoholic fatty liver disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30652643",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33179890",
                    "mediaDataId": 0,
                    "title": "Nonalcoholic fatty liver disease: common questions and answers on diagnosis and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33179890",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 137,
            "othersAvgTimeSpent": 71,
            "notes": null,
            "peopleTaken": 20482,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 815,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 3194,
            "questionIndex": 3194,
            "questionText": "<p>A previously healthy 2-year-old girl is brought to the hospital due to lethargy and confusion for 1 day.&nbsp; Four days ago, the patient developed fever and nasal discharge.&nbsp; These symptoms resolved in 2 days, but she has been progressively tired and disoriented for the past day.&nbsp; The patient&#39;s older sister had a cold sore on her lip 2 weeks ago.&nbsp; Temperature is 37.1 C (98.8 F).&nbsp; On examination, she is minimally responsive.&nbsp; The pupils are equal and have a sluggish reaction to light.&nbsp; The sclerae are nonicteric, and the neck is supple.&nbsp; Mild hepatomegaly is present.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td style=\"vertical-align:middle;\">16 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td style=\"vertical-align:middle;\">50 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td style=\"vertical-align:middle;\">1.1 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td style=\"vertical-align:middle;\">120 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">706 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">814 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Ammonia</td><td style=\"vertical-align:middle;\">105 &micro;g/dL (normal: 40-70)</td></tr></tbody></table><p>CT scan of the head reveals diffuse cerebral edema.&nbsp; Which of the following is most helpful to establish a diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32373\"><table class=\"table-default-style table-footer-only-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Reye syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Aspirin use in children during viral infection (eg, influenza, varicella)</li><li>Microvesicular fat deposits in the liver</li><li>Cerebral edema</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Acute liver failure<ul style=\"list-style-type:circle;\"><li>Hepatomegaly without jaundice</li></ul></li><li>Rapidly progressive encephalopathy<ul style=\"list-style-type:circle;\"><li>Vomiting, lethargy, seizure, coma</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>&#8593; AST, ALT, ammonia</li><li>&#8593; PT, INR, PTT</li><li>&#8595; Glucose</li><li>Metabolic acidosis</li><li>Normal bilirubin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Supportive</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALT</strong> = alanine aminotransferase (SGPT); <strong>AST</strong> = aspartate aminotransferase (SGOT).</p></td></tr></tbody></table></div><p>This patient&#39;s rapid onset of <strong>encephalopathy</strong>, liver failure, and <strong>cerebral edema</strong> is concerning for <strong>Reye syndrome</strong>.&nbsp; This potentially fatal illness is seen in young children treated with <strong>salicylates</strong> (eg, aspirin) for a viral infection (eg, <strong>influenza</strong>, varicella).&nbsp; The incidence of Reye syndrome has significantly decreased since the avoidance of <strong>aspirin</strong> in the management of pediatric fever.&nbsp; However, sporadic cases have been linked to unintentional salicylate administration when caregivers are unaware of the contents of over-the-counter medications.&nbsp; Obtaining a thorough <strong>medication history</strong> in this child would help to establish the diagnosis.</p><p>Pathogenesis of Reye syndrome likely relates to impaired fatty acid metabolism due to mitochondrial dysfunction, which results in hepatic dysfunction leading to ammonia accumulation and resultant astrocyte edema.&nbsp; Presenting signs include vomiting and confusion after recovery from a viral illness, as seen here.&nbsp; Encephalopathy (ie, disorientation, lethargy) and cerebral edema can <strong>progress rapidly</strong> to seizure, coma, and death.</p><p>Characteristic laboratory findings in Reye syndrome, including <strong>elevated aminotransferases</strong>, <strong>hyperammonemia</strong>, and <strong>coagulopathy</strong> (ie, prolonged PT, INR, and PTT), reflect <strong>hepatic dysfunction</strong> due to microvesicular fatty deposits.&nbsp; <strong>Metabolic acidosis</strong> (ie, low bicarbonate) is typically present, and <strong>hypoglycemia</strong> may result from decreased hepatic glucose production.&nbsp; Regardless of the degree of liver involvement, total <strong>bilirubin</strong> usually is <strong>normal</strong> or minimally elevated, and jaundice/icterus is not typical.</p><p><strong>(Choice A)</strong>&nbsp; Cholinergic toxicity (eg, organophosphate exposure) presents with vomiting, diarrhea, miosis, and bradycardia, as well as excess urination, tearing, and salivation.&nbsp; These findings are not present in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Unimmunized patients are at increased risk for hepatitis A and B infections, which cause elevated aminotransferases; however, hyperbilirubinemia and scleral icterus (not seen in this patient) would generally be expected in such cases.&nbsp; In addition, progression of viral hepatitis to hepatic encephalopathy typically is gradual, in contrast to this patient&#39;s rapid deterioration in mental status.</p><p><strong>(Choice D)</strong>&nbsp; Children with encephalopathy should be evaluated for encephalitis with spinal fluid analysis.&nbsp; However, CNS infection is unlikely in this patient given the absence of persistent fever.&nbsp; Opening pressure may be elevated with Reye syndrome, but cerebrospinal fluid analysis is otherwise normal and does not aid in diagnosis.</p><p><strong>(Choice E)</strong>&nbsp; Urine reducing substances primarily screen for inborn errors of carbohydrate metabolism (eg, galactosemia).&nbsp; Although hypoglycemia and hepatomegaly can occur, these conditions typically present in infancy and do not cause hyperammonemia.</p><p><strong>Educational objective:</strong><br>Reye syndrome presents in young children with rapidly progressive encephalopathy and hepatic dysfunction after aspirin administration for a viral infection.&nbsp; Characteristic laboratory findings include elevated aminotransferases and hyperammonemia.&nbsp; Coagulopathy, hypoglycemia, and metabolic acidosis are also common.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 15347,
            "topic": "Reye syndrome",
            "titleId": 15347,
            "title": "Reye syndrome",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "History of organophosphate exposure",
                    "choiceNumber": 1,
                    "correctTaken": 475,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Immunization status",
                    "choiceNumber": 2,
                    "correctTaken": 3492,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication history",
                    "choiceNumber": 3,
                    "correctTaken": 7759,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Spinal fluid analysis",
                    "choiceNumber": 4,
                    "correctTaken": 2875,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urine reducing substances",
                    "choiceNumber": 5,
                    "correctTaken": 2071,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "134,189,true,-1,1*228,257,true,-1,1*377,381,true,-1,1*392,427,true,-1,1*1174,1386,true,-1,1*1963,2103,true,-1,1*2389,2418,true,-1,1*2466,2737,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "639",
                    "mediaDataId": 0,
                    "title": "Reye syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "673",
                    "mediaDataId": 0,
                    "title": "Salicylate (aspirin) toxicity",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27418941",
                    "mediaDataId": 0,
                    "title": "Acetylsalicylic acid as a potential pediatric health hazard: legislative aspects concerning accidental intoxications in the European Union.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27418941",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30252357",
                    "mediaDataId": 0,
                    "title": "Reye syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30252357",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 91,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 16672,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1026,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 2907,
            "questionIndex": 2907,
            "questionText": "<p>A 54-year-old man comes to the office due to 6 months of fatigue, anorexia, and a 7-kg (15.4-lb) unintentional weight loss.&nbsp; The patient has noticed that, despite his weight loss, his pants are getting tighter and his socks leave deep imprints on his legs.&nbsp; Medical history is significant for hypertension for which he takes amlodipine.&nbsp; He was adopted and is unaware of his biologic family history.&nbsp; The patient has smoked 5 or 6 cigarettes daily for the past 30 years and drinks 1 or 2 cans of beer on weekends.&nbsp; He has a remote history of intravenous drug use.&nbsp; Blood pressure is 134/82 mm Hg and pulse is 84/min.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination of the upper torso shows several telangiectasias consisting of central arterioles surrounded by many smaller vessels.&nbsp; Breast glandular tissue is enlarged, firm, and nontender bilaterally.&nbsp; Cardiac examination demonstrates normal heart sounds without murmurs.&nbsp; Breath sounds are decreased at the bases.&nbsp; The abdomen is soft, nontender, and distended with shifting dullness.&nbsp; There is bilateral lower extremity pitting edema.&nbsp; Which of the following is the most likely underlying cause of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"3269\" src=\"https://www.uworld.com/media/highresdefault/L25246.jpg\"  ></p><p>This patient&#39;s spider angiomas (ie, telangiectasias), gynecomastia, lower extremity edema, and ascites (eg, shifting dullness)&nbsp;suggest <strong>cirrhosis</strong>.&nbsp; Common causes include heavy alcohol use, nonalcoholic fatty liver disease (NAFLD), hemochromatosis, and chronic viral hepatitis.</p><p>Initial evaluation of cirrhosis involves thorough history-taking, including medications, social habits (eg, alcohol use, drug use, high-risk sexual activity), and family history (eg, to exclude hemochromatosis).&nbsp; This patient has no significant alcohol history, a normal BMI (making NALFD unlikely), and no stigmata of hemochromatosis (eg, bronze diabetes, cardiomyopathy).&nbsp; Given prior <strong>intravenous drug use</strong> (IVDU), he likely has <strong>chronic viral hepatitis</strong> (~50% of cirrhosis cases with alcohol).&nbsp; Laboratory studies, including viral hepatitis serologies and iron studies, should be obtained.&nbsp; If these are unrevealing, further investigation for less common causes may be required.</p><p>Cirrhosis can be caused by hepatitis B (most common worldwide) or <strong>hepatitis C virus</strong> (most common in the United States), with hepatitis C more strongly linked to IVDU.&nbsp; Chronic viral infection of hepatocytes can cause progressive liver inflammation, fibrosis, and eventually cirrhosis.&nbsp; <strong>Antiviral medications</strong> stop liver inflammation and reverse fibrosis, thereby prolonging survival.</p><p><strong>(Choice A)</strong>&nbsp; Amlodipine commonly causes pedal edema due to selective arteriolar dilation but would not explain this patient&#39;s other examination findings.</p><p><strong>(Choice C)</strong>&nbsp; Cor pulmonale (ie, right ventricular failure), due to pulmonary hypertension, can cause lower extremity edema and ascites.&nbsp; A loud S2 is often auscultated; spider angiomas and gynecomastia are not typical.</p><p><strong>(Choice D)</strong>&nbsp; Hypothyroidism can cause fatigue, anorexia, edema, and, rarely, ascites.&nbsp; However, edema due to hypothyroidism is nonpitting (vs pitting in this patient), and gynecomastia and spider angiomas would not be expected.</p><p><strong>(Choice E)</strong>&nbsp; Lung cancer could lead to fatigue, weight loss, anorexia, edema of the legs, and ascites in patients with advanced disease (eg, metastatic compression of the lymphatics, peritoneal carcinomatosis).&nbsp; However, this patient&#39;s gynecomastia, spider angiomas, and history of IVDU make cirrhosis more likely.&nbsp; Ascites can impair diaphragmatic excursion and cause atelectasis (decreased breath sounds).&nbsp; Cirrhosis also commonly causes weight loss due to muscle wasting (despite volume overload).</p><p><strong>(Choice F)</strong>&nbsp; Nephrotic syndrome can cause anasarca but is not usually associated with spider angiomas or gynecomastia.</p><p><strong>Educational objective:</strong><br>Cirrhosis should be suspected in patients with stigmata of chronic liver disease (eg, spider angiomas, gynecomastia, ascites).&nbsp; Common causes include heavy alcohol use, nonalcoholic fatty liver disease, hemochromatosis, and chronic viral hepatitis B (worldwide) or C (United States).&nbsp; Prior or current use of intravenous drugs is a strong risk factor for hepatitis C.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 2874,
            "topic": "Cirrhosis",
            "titleId": 2874,
            "title": "Cirrhosis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adverse medication effect",
                    "choiceNumber": 1,
                    "correctTaken": 954,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chronic viral infection",
                    "choiceNumber": 2,
                    "correctTaken": 12010,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cor pulmonale",
                    "choiceNumber": 3,
                    "correctTaken": 904,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothyroidism",
                    "choiceNumber": 4,
                    "correctTaken": 85,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lung cancer",
                    "choiceNumber": 5,
                    "correctTaken": 1629,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nephrotic syndrome",
                    "choiceNumber": 6,
                    "correctTaken": 867,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "177,307,true,-1,1*802,986,true,-1,1*987,1152,true,-1,1*1980,2177,true,-1,1*2283,2467,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "356",
                    "mediaDataId": 0,
                    "title": "Hepatitis A, D, and E virus infection",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "390",
                    "mediaDataId": 0,
                    "title": "Hepatitis C virus (HCV) infection",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "410",
                    "mediaDataId": 0,
                    "title": "Cirrhosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "36405106",
                    "mediaDataId": 0,
                    "title": "Epidemiology of liver cirrhosis and associated complications: current knowledge and future directions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/36405106",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 168,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 16449,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1618,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 4498,
            "questionIndex": 4498,
            "questionText": "<p>A 24-year-old man is brought to the emergency department after the all-terrain vehicle he was driving rolled over and landed on him.&nbsp; Blood pressure is 82/50 mm Hg, pulse is 128/min, and respirations are 24/min.&nbsp; The patient is alert but anxious and diaphoretic.&nbsp; He has a scalp laceration that has stopped bleeding.&nbsp; The pupils are equal and reactive to light.&nbsp; The trachea is midline.&nbsp; Bruising is present over the chest wall and abdomen.&nbsp; Breath sounds are present bilaterally.&nbsp; Heart sounds are normal.&nbsp; The abdomen is distended and has diffuse tenderness.&nbsp; Portable chest x-ray shows fracture of multiple ribs, including the right eighth and ninth ribs and the left fourth rib, with no pneumothorax.&nbsp; Focused Assessment with Sonography for Trauma shows no pericardial effusion but a large amount of intraperitoneal free fluid.&nbsp; Pelvic x-ray is negative for fractures.&nbsp; The patient remains hypotensive after the rapid infusion of 2 L of intravenous crystalloid and is taken for emergency exploratory laparotomy.&nbsp; Which of the following injuries is the most likely cause of this patient&#39;s persistent hypotension?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"5060\" src=\"https://www.uworld.com/media/L14.jpg\" ></p><p>This patient with blunt abdominal trauma (BAT) has signs of <strong>hypovolemic shock</strong> (eg, severe hypotension, tachycardia) due to <strong>intraabdominal hemorrhage</strong> (eg, abdominal distension, intraperitoneal free fluid).&nbsp; Given the patient&#39;s concomitant fractures of the right lower ribs, which signal likely <strong>trauma of the right upper quadrant</strong> (RUQ), this presentation is most consistent with <strong>liver laceration</strong>.</p><p>The liver is one of the&nbsp;most frequently injured organs in BAT, with the spectrum of injury ranging from subcapsular hematoma to parenchymal disruption (ie, laceration) causing bleeding into the peritoneum.&nbsp; Trauma to the RUQ, right lower rib cage (eg, right eighth and ninth ribs), or right flank should raise suspicion for hepatic injury.</p><p><a href=\"26186\">Triage of patients with BAT</a> without frank peritonitis (eg, abdominal rigidity, rebound tenderness) includes bedside Focused Assessment with Sonography for Trauma (FAST) to assess for intraperitoneal free fluid, a marker of intraabdominal organ injury.&nbsp; As in this case, hemodynamically unstable (eg, systolic blood pressure &lt;90 mm Hg) patients with a positive FAST should undergo exploratory laparotomy.</p><p><strong>(Choice A)</strong>&nbsp; Abdominal aortic injuries due to BAT are rare (&lt;1%).&nbsp; Many patients with traumatic aortic injury die from exsanguination before reaching the hospital.&nbsp; Those who survive (because bleeding has been contained within the retroperitoneum) typically would not have a large amount of intraperitoneal free fluid on FAST.</p><p><strong>(Choices B and E)</strong>&nbsp; BAT can cause duodenal and splenic hematoma from intraluminal and subcapsular bleeding, respectively.&nbsp; However, because the bleeding is contained within the lumen or capsule, hematoma formation often tamponades further bleeding, making such a severe degree of shock (eg, unresponsive to 2 L of volume resuscitation) less common.&nbsp; In addition, neither type of hematoma would cause intraperitoneal free fluid.</p><p><strong>(Choice D)</strong>&nbsp; Pancreatic injuries can occur with BAT, especially when the pancreas is crushed against the vertebral column by an anterior blow to the central abdomen.&nbsp; However, because of its retroperitoneal location, even severe injuries to the pancreas (eg, transection with pancreatic fluid leakage) typically do not cause intraperitoneal free fluid.</p><p><strong>(Choice F)</strong>&nbsp; Urinary bladder rupture can occur from BAT, especially with pelvic fractures.&nbsp; Patients often have evidence of intraperitoneal free fluid (ie, urine) on FAST, but significant hemodynamic instability is uncommon.&nbsp; In addition, gross hematuria is typically present.</p><p><strong>Educational objective:</strong><br>The liver is one of the most commonly injured organs in blunt abdominal trauma.&nbsp; Patients with severe liver laceration causing intraabdominal hemorrhage may have shock and intraperitoneal free fluid on Focused Assessment with Sonography for Trauma.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 271,
            "topic": "Blunt abdominal trauma",
            "titleId": 271,
            "title": "Blunt abdominal trauma",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abdominal aortic injury",
                    "choiceNumber": 1,
                    "correctTaken": 2050,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Duodenal hematoma",
                    "choiceNumber": 2,
                    "correctTaken": 354,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Liver laceration",
                    "choiceNumber": 3,
                    "correctTaken": 11167,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pancreatic transection",
                    "choiceNumber": 4,
                    "correctTaken": 206,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Splenic hematoma",
                    "choiceNumber": 5,
                    "correctTaken": 3002,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urinary bladder rupture",
                    "choiceNumber": 6,
                    "correctTaken": 190,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "634,766,true,-1,1*1036,1170,true,-1,1*1223,1228,true,-1,1*1237,1331,true,-1,1*1353,1417,true,-1,1*1690,1843,true,-1,1*2099,2275,true,-1,1*2332,2365,true,-1,1*2450,2499,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26038039",
                    "mediaDataId": 0,
                    "title": "Management of blunt liver injury: what is new?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26038039",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21818009",
                    "mediaDataId": 0,
                    "title": "Western Trauma Association/critical decisions in trauma: operative management of adult blunt hepatic trauma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21818009",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 284,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 16969,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1463,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 2899,
            "questionIndex": 2899,
            "questionText": "<p>A 55-year-old man comes to the office reporting &#x22;a swollen belly and puffy feet&#x22; that began several months ago.&nbsp; He has not seen a physician for several years but says that he was previously diagnosed with depression.&nbsp; The patient takes no medications.&nbsp; He currently lives alone and is unemployed.&nbsp; He admits to drinking 6-12 beers a night, depending on what he can afford.&nbsp; He has a remote history of cigarette smoking.&nbsp; Physical examination reveals bilateral gynecomastia, spider angiomas on the chest, Dupuytren contracture of both hands, and palmar erythema.&nbsp; Dilated periumbilical veins are also visible.&nbsp; Percussion of the abdomen demonstrates shifting dullness.&nbsp; Splenomegaly is present.&nbsp; There is no evidence of asterixis.&nbsp; There is pitting edema of the lower extremities.&nbsp; Laboratory studies reveal increased prothrombin time and thrombocytopenia.&nbsp; Which of the following findings has the same pathogenesis as spider angiomas?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"3269\" src=\"https://www.uworld.com/media/highresdefault/L25246.jpg\"  ></p><p>This patient has numerous findings suggestive of alcoholic <strong>cirrhosis</strong> of the liver.&nbsp; Cirrhosis of any type leads to progressive loss of liver function, which can be divided into 3 categories: synthetic (production of clotting factors, cholesterol, and proteins); <strong>metabolic</strong> (metabolism of drugs and corticosteroids, including detoxification); and excretory (bile excretion).</p><p>In patients with cirrhosis, <strong>spider angioma</strong> and <strong>palmar erythema</strong> both arise from <strong>hyperestrinism</strong> due to impaired hepatic metabolism of circulating estrogens, a process that begins in the cytochrome P450 system.&nbsp; Circulating estrogens affect vascular wall dilation.&nbsp; <a href=\"2644\">Spider angioma</a> consists of a central, dilated arteriole surrounded by smaller radiating vessels.&nbsp; Palmar erythema is a result of increased normal speckling of the palm due to increased vasodilation, especially at the thenar and hypothenar eminences.&nbsp; Other manifestations of hyperestrinism in patients with cirrhosis include gynecomastia, testicular atrophy, and decreased body hair in males.</p><p><strong>(Choices A and E)</strong>&nbsp; <a href=\"311\">Caput medusae</a> arise from the dilation of superficial veins on the abdominal wall due to portal hypertension (PH).&nbsp; PH results from increased resistance to portal flow at the sinusoids and leads to increased pressure at the portosystemic collateral veins in the anterior abdomen, rectum, and distal esophagus.&nbsp; This then predisposes to esophageal varices, rectal varices, and caput medusae.&nbsp; Similarly, PH causes enlargement of the spleen (which drains into the portal vein via the splenic vein) due to vascular congestion of the red pulp.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"28431\">Dupuytren contracture</a> occurs when the palmar fascia thickens and shortens, deforming the hand.&nbsp; It is usually most notable initially in the fourth and fifth digits and occurs due to fibroblast proliferation and collagen deposition, which are likely worsened by oxidative stress from increased free radical production.</p><p><strong>(Choice D)</strong>&nbsp; The liver is the primary site of protein synthesis, and the cirrhotic liver typically produces insufficient amounts of proteins, including albumin.&nbsp; Hypoalbuminemia leads to both a decrease in the intravascular oncotic pressure and fluid shifts to the extravascular space, predisposing to edema of the lower extremities.</p><p><strong>Educational objective:</strong><br>Hyperestrinism in cirrhosis leads to gynecomastia, testicular atrophy, decreased body hair, spider angiomas, and palmar erythema.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 2874,
            "topic": "Cirrhosis",
            "titleId": 2874,
            "title": "Cirrhosis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Dilated abdominal veins",
                    "choiceNumber": 1,
                    "correctTaken": 3043,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dupuytren contracture",
                    "choiceNumber": 2,
                    "correctTaken": 315,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Palmar erythema",
                    "choiceNumber": 3,
                    "correctTaken": 12359,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pedal edema",
                    "choiceNumber": 4,
                    "correctTaken": 265,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Splenomegaly",
                    "choiceNumber": 5,
                    "correctTaken": 402,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "614,666,true,-1,1*765,918,true,-1,1*1482,1618,true,-1,1*1741,1948,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "355",
                    "mediaDataId": 0,
                    "title": "Complications of cirrhosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "410",
                    "mediaDataId": 0,
                    "title": "Cirrhosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16970019",
                    "mediaDataId": 0,
                    "title": "Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16970019",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16970020",
                    "mediaDataId": 0,
                    "title": "Cirrhosis and chronic liver failure: part II. Complications and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16970020",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22356347",
                    "mediaDataId": 0,
                    "title": "Images in clinical medicine. Spider angioma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22356347",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 79,
            "othersAvgTimeSpent": 36,
            "notes": null,
            "peopleTaken": 16384,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 589,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 2896,
            "questionIndex": 2896,
            "questionText": "<p>A 5-year-old, previously healthy, girl is brought to the emergency department due to lethargy and altered mental status.&nbsp; The patient was in her usual state of health until 5 days ago, when she developed a fever, malaise, headache, cough, and nasal discharge.&nbsp; The fever resolved with over-the-counter medications, and the patient was feeling better until this morning, when she developed nausea, vomiting, and lethargy.&nbsp; She has no chronic medical conditions and takes no prescription medications.&nbsp; Temperature is 36.8 C (98.2 F), blood pressure is 98/60 mm Hg, pulse is 110/min, and respirations are 20/min.&nbsp; The patient is not oriented to person, place, or time.&nbsp; Cardiopulmonary examination shows no abnormalities.&nbsp; Hepatomegaly is present; there is no splenomegaly.&nbsp; CT scan of the head reveals diffuse cerebral edema.&nbsp; Which of the following is the most likely cause of this patient&#39;s imaging findings?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T69755\"><table class=\"table-default-style table-header-footer-style\" style=\"width:560px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Toxic-metabolic encephalopathy* &amp; cerebral edema</strong></p></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><p align=\"center\"><strong>Precipitating factors</strong></p></td></tr><tr><td><p align=\"center\"><strong>Hypoxic-ischemic<br>encephalopathy</strong></p></td><td><ul><li>Near-drowning event</li><li>Choking episode</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diabetic ketoacidosis</strong></p></td><td><ul><li>Poorly controlled diabetes mellitus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hyponatremia</strong></p></td><td><ul><li>SIADH</li><li>Rapid correction of hypernatremia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Liver failure</strong></p></td><td><ul><li>Viral or autoimmune hepatitis</li><li>Hepatotoxic drugs (eg, acetaminophen)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Reye syndrome</strong></p></td><td><ul><li>Aspirin administration for viral illness in children</li></ul></td></tr><tr><td colspan=\"2\"><p>*Acute cerebral dysfunction/mental status changes in the absence of primary CNS pathology.</p><p><strong>SIADH</strong> = syndrome of inappropriate antidiuretic hormone secretion.</p></td></tr></tbody></table></div><p>This patient has acutely altered mental status and cerebral edema on CT scan, findings concerning for <strong>toxic-metabolic encephalopathy</strong>.&nbsp; The potential underlying etiologies are vast and are characterized by brain dysfunction in the absence of primary CNS disease (eg, infection, tumor).&nbsp; In this case, the patient&#39;s recent upper respiratory infection treated with over-the-counter medications, hepatomegaly, and rapid progression make <strong>Reye syndrome</strong> most likely.</p><p><a href=\"15439\">Reye syndrome</a> is a rare but potentially fatal condition that occurs in children who were given <strong>salicylates</strong> (eg, aspirin) for a <strong>viral illness</strong> (eg, influenza, varicella).&nbsp; The pathophysiology likely involves mitochondrial dysfunction from aspirin, which leads to impaired fatty acid metabolism and acute hepatic steatosis, as seen by this patient&#39;s <strong>hepatomegaly</strong>.&nbsp; With declining liver function, <strong>excess ammonia</strong> (ie, neurotoxin) accumulates and causes <strong>cerebral edema</strong> and encephalopathy (ie, altered mental status).&nbsp; Initial symptoms of increased intracranial pressure (ie, vomiting, lethargy) can rapidly progress to seizures, coma, and death.</p><p>Liver biopsy showing microvesicular steatosis in the context of acute toxic-metabolic encephalopathy is consistent with Reye syndrome but is not required for the diagnosis.&nbsp; Treatment is supportive, and parents should be reminded that aspirin is contraindicated in children except in the management of Kawasaki disease and rheumatologic diseases (eg, juvenile idiopathic arthritis).</p><p><strong>(Choice A)</strong>&nbsp; Adrenal crisis can be precipitated by infection and cause hypotension, vomiting, and acute mental status changes.&nbsp; However, cerebral dysfunction is due to poor perfusion, not cerebral edema, from lack of cortisol.&nbsp; This patient&#39;s hepatomegaly, cerebral edema, and normal blood pressure make adrenal insufficiency unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Hypoglycemia, which can cause confusion and lethargy, may occur in Reye syndrome from decreased hepatic production of glucose but does not cause cerebral edema.&nbsp; Cerebral edema can be caused by hyperglycemia (eg, diabetic ketoacidosis), but this metabolic derangement is not seen in Reye syndrome.</p><p><strong>(Choice D)</strong>&nbsp; Severe hypothyroidism (myxedema coma) can present with lethargy and disorientation, but hypothermia and bradycardia would also be present.&nbsp; In addition, hypothyroidism does not cause hepatomegaly or cerebral edema.</p><p><strong>(Choice E)</strong>&nbsp; Urea is a neurotoxin that, in excess (eg, renal failure), can cause altered mental status (ie, uremic encephalopathy) but not cerebral edema.&nbsp; Signs of renal impairment (eg, hypertension, peripheral edema), not hepatomegaly, would be expected.</p><p><strong>Educational objective:</strong><br>Reye syndrome is a rare toxic-metabolic encephalopathy in children who have taken aspirin for a viral illness.&nbsp; Liver failure (microvesicular hepatic steatosis) leads to hyperammonemia, cerebral edema, and encephalopathy (ie, altered mental status).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 15347,
            "topic": "Reye syndrome",
            "titleId": 15347,
            "title": "Reye syndrome",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adrenal insufficiency",
                    "choiceNumber": 1,
                    "correctTaken": 1057,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hyperammonemia",
                    "choiceNumber": 2,
                    "correctTaken": 8238,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypoglycemia",
                    "choiceNumber": 3,
                    "correctTaken": 1188,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothyroidism",
                    "choiceNumber": 4,
                    "correctTaken": 54,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uremia",
                    "choiceNumber": 5,
                    "correctTaken": 1355,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1869,2076,true,-1,1*2214,2304,true,-1,1*2588,2661,true,-1,1*2823,2873,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20000310",
                    "mediaDataId": 0,
                    "title": "FPIN&#39;s clinical inquiries.  Aspirin use in children for fever or viral syndromes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20000310",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 67,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 11892,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 757,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 15579,
            "questionIndex": 17014,
            "questionText": "<p>A 48-year-old man comes to the emergency department due to fever and malaise for the past 2 days.&nbsp; He also complains of fatigue and lethargy but not nausea, vomiting, diarrhea, or dysuria.&nbsp; Medical history is significant for alcoholic cirrhosis, which was treated with an orthotopic liver transplant 10 weeks ago.&nbsp; Current medications include tacrolimus, mycophenolate mofetil, and low-dose prednisone.&nbsp; Temperature is 38.1 C (100.6 F), blood pressure is 125/82, pulse is 80/min, and respirations are 12/min.&nbsp; The patient is awake and oriented to person, place, and time.&nbsp; Scleral icterus is present.&nbsp; Cardiopulmonary examination is unremarkable.&nbsp; There is a well-healed surgical scar on the abdomen but no tenderness or distension.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"3\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">12.9 g/dL</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">6,000/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">345,000/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td style=\"vertical-align:middle;\">3.2 mg/dL</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td style=\"vertical-align:middle;\">378 U/L</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">345 U/L</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">473 U/L</td><td style=\"vertical-align:middle;\"></td></tr></tbody></table><p>A liver biopsy shows inflammatory infiltration of the portal tracts consisting of lymphocytes, eosinophils, and neutrophils.&nbsp; Interlobular bile duct destruction and prominent endotheliitis are both present.&nbsp; Which of the following is the best next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient with a recent liver transplant&nbsp;who now has fevers, malaise, and liver function test (LFT) elevations exhibits histologic findings concerning for <strong>acute cellular rejection</strong> (ACR).</p><p>ACR usually occurs <strong>within the first 3 months</strong> after transplant and results from the patient&#39;s own immune system targeting the liver allograft.&nbsp; Although some patients have <strong>fevers</strong>, malaise, and lethargy, many are completely asymptomatic.&nbsp; Therefore, in patients with a recent liver transplant, ACR is often suspected based upon the development of <strong>LFT&nbsp;abnormalities</strong> (eg, elevations in aminotransferases, bilirubin, and alkaline phosphatase).&nbsp; Definitive diagnosis is made by <strong>liver biopsy</strong>, which classically reveals:</p><ul><li>mixed <strong>inflammatory infiltration</strong> of the portal tracts involving eosinophils, neutrophils, and lymphocytes</li><li>interlobular bile duct destruction (often referred to as nonsuppurative cholangitis)</li><li><strong>endotheliitis</strong> (ie, lymphocytic subendothelial invasion of the portal and hepatic veins), which is the most&nbsp;reliable sign of ACR.</li></ul><p>The mainstay of therapy for ACR is <strong>increased immunosuppression</strong>, which typically reverses the rejection.&nbsp; Most patients are treated successfully with <strong>high-dose corticosteroids</strong>.&nbsp; In steroid-refractory cases, thymoglobulin, sirolimus, and other immunosuppressants can be used.&nbsp; Very rarely, if a patient fails to respond to any immunosuppressant, a repeat transplant is required.</p><p><strong>(Choice B)</strong>&nbsp; The immunosuppressant mycophenolate is most commonly associated with cytopenias and gastrointestinal (eg, pain, vomiting, diarrhea) side effects.&nbsp; It is generally discontinued&nbsp;in patients with active infection due to the risk of neutropenia.&nbsp; This patient&#39;s findings do not suggest side effects of mycophenolate (eg, no cytopenia, no gastrointestinal symptoms), and his&nbsp;biopsy results are consistent with ACR.</p><p><strong>(Choice C)</strong>&nbsp; Ursodeoxycholic acid is used in the treatment of primary biliary cholangitis (PBC).&nbsp; The classic histologic finding in PBC is a florid duct lesion, defined as inflammation limited to the bile duct.&nbsp; Endotheliitis and mixed-inflammatory infiltration of the portal tract are not expected in PBC.</p><p><strong>(Choice D)</strong>&nbsp; Calcineurin inhibitors (eg, tacrolimus) are associated with acute renal injury, but significant hepatic injury is rare.&nbsp; Dose reduction is not indicated and would likely worsen the ACR in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Metronidazole is commonly used to treat intraabdominal abscesses or other infections that can occur in the posttransplant period.&nbsp; Such an infection would present with fever and, potentially, transaminase elevations; however, leukocytosis is expected and the infection would not explain this patient&#39;s histologic findings.</p><p><strong>Educational objective:</strong><br>Acute cellular rejection typically occurs within the first 3 months after liver transplant and can present with fevers, malaise, and a rise in aminotransferases, bilirubin, and alkaline phosphatase.&nbsp; Liver biopsy is diagnostic, demonstrating mixed inflammatory infiltration of the portal tracts, interlobular bile duct destruction, and endotheliitis.&nbsp; Most patients can be treated successfully with high-dose corticosteroids.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 21875,
            "topic": "Transplant rejection",
            "titleId": 21875,
            "title": "Transplant rejection",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer high-dose corticosteroids",
                    "choiceNumber": 1,
                    "correctTaken": 15544,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue mycophenolate",
                    "choiceNumber": 2,
                    "correctTaken": 1209,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate ursodeoxycholic acid therapy",
                    "choiceNumber": 3,
                    "correctTaken": 1765,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reduce the tacrolimus dose",
                    "choiceNumber": 4,
                    "correctTaken": 1169,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start metronidazole therapy",
                    "choiceNumber": 5,
                    "correctTaken": 888,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "362,1051,true,-1,1*1156,1228,true,-1,1*1229,1325,true,-1,1*1440,1681,true,-1,1*1952,2060,true,-1,1*2169,2247,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29996675",
                    "mediaDataId": 0,
                    "title": "Acute allograft rejection in liver transplant recipients: incidence, risk factors, treatment success, and impact on graft failure.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29996675",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29234201",
                    "mediaDataId": 0,
                    "title": "Acute and chronic rejection after liver transplantation: what a clinician needs to know.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29234201",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 107,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 20575,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1461,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 2925,
            "questionIndex": 2925,
            "questionText": "<p>A 37-year-old woman, gravida 2 para 1, comes to the emergency department due to decreased fetal movement over the past 2 days.&nbsp; She has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; The pregnancy was uncomplicated until a few weeks ago when the patient began to experience generalized itching that is worse on her hands and feet.&nbsp; She has also had nausea for the past 3 days but no vomiting or diarrhea.&nbsp; The patient recently immigrated to the United States and has received no prenatal care.&nbsp; Temperature is 37 C (98.6 F) and blood pressure is 134/76 mm Hg.&nbsp; Fundal height is 38 cm.&nbsp; There is no scleral icterus.&nbsp; Cardiac and pulmonary examinations are normal.&nbsp; The right upper quadrant is tender to palpation, but there is no rebound or guarding.&nbsp; Bilateral lower extremities have 1+ pitting edema.&nbsp; Diffuse excoriations are noted on the skin.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Hemoglobin</td><td style=\"vertical-align:middle;\">12.3 g/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Mean corpuscular volume</td><td style=\"vertical-align:middle;\">91 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Platelets</td><td style=\"vertical-align:middle;\">140,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Leukocytes</td><td style=\"vertical-align:middle;\">8,200/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Total bilirubin</td><td colspan=\"2\" style=\"vertical-align:middle;\">2.4 mg/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Direct bilirubin</td><td colspan=\"2\" style=\"vertical-align:middle;\">1.1 mg/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Total bile acids</td><td colspan=\"2\" style=\"vertical-align:middle;\">110 &micro;mol/L (normal: &lt;10)</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Alkaline phosphatase</td><td colspan=\"2\" style=\"vertical-align:middle;\">200 U/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Aspartate aminotransferase (SGOT)</td><td colspan=\"2\" style=\"vertical-align:middle;\">516 U/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Alanine aminotransferase (SGPT)</td><td colspan=\"2\" style=\"vertical-align:middle;\">884 U/L</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Hepatitis panel</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Hepatitis B surface antigen</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Hepatitis B surface antibody</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Antibody to hepatitis B core antigen</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">IgM antibody to hepatitis A virus</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">IgG antibody to hepatitis A virus</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Hepatitis C virus antibody</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>Transabdominal ultrasonography reveals a 38-week intrauterine gestation with no fetal cardiac activity.&nbsp; Which of the following is the most likely cause of this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T40285\" style=\"overflow-x:auto;\" tid=\"15384\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Intrahepatic cholestasis of pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Development in 3rd trimester</li><li>Generalized pruritus</li><li>Pruritus worse on hands &amp; feet</li><li>No associated rash</li><li>Right upper quadrant pain</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory abnormalities</strong></p></td><td><ul><li>&#8593; Total bile acids (&#8805;10 &micro;mol/L)</li><li>&#8593; Liver transaminases (typically &lt;2&times; normal, rarely &gt;1,000 U/L)</li><li>&plusmn; &#8593; Total &amp; direct bilirubin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Obstetric risks</strong></p></td><td><ul><li>Intrauterine fetal demise</li><li>Preterm delivery</li><li>Meconium-stained amniotic fluid</li><li>Neonatal respiratory distress syndrome</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Ursodeoxycholic acid</li><li>Antihistamines</li><li>Delivery at 37 weeks gestation</li></ul></td></tr></tbody></table></div><p>This patient&#39;s elevated total bile acids and fetal demise are consistent with <strong>intrahepatic cholestasis of pregnancy (ICP)</strong>.&nbsp; ICP typically occurs in the third trimester because increased estrogen and progesterone cause hepatobiliary tract stasis and decreased bile excretion.&nbsp; This results in <strong>elevated total bile acids (&#8805;10 &micro;mol/L)</strong>, which accumulate in the liver (resulting in elevated aminotransferase and bilirubin levels) and skin (resulting in <strong>pruritus</strong> that is worse on the <strong>hands and feet</strong>).&nbsp; Risk factors include prior ICP, maternal age &#8805;35, and multiple gestation.</p><p>Although ICP does not cause maternal complications, bile acids can cross the placenta and cause <strong>fetal complications</strong>, as seen in this case.&nbsp; The maternal serum bile acid level is directly proportional to the risk of complications because bile acids accumulate in the fetal circulation and become increasingly toxic.&nbsp; The risk of <strong>intrauterine fetal demise (IUFD)</strong> is particularly high when serum bile acid level is &#8805;100 &micro;mol/L.&nbsp; Additional complications of ICP include preterm delivery, meconium-stained amniotic fluid, and neonatal respiratory distress.</p><p>Because of the risk of IUFD, management of ICP includes ursodeoxycholic acid (which can decrease bile acid level), frequent antepartum monitoring (eg, nonstress test), and delivery by 37 weeks gestation.</p><p><strong>(Choice A)</strong>&nbsp; Acute fatty liver of pregnancy can present with right upper quadrant pain, elevated aminotransferases, and IUFD.&nbsp; However, patients typically have symptoms of fulminant liver failure (eg, scleral icterus, encephalopathy), leukocytosis, and platelet count &#8804;100,000/mm<font size=\"2\"><sup>3</sup></font>.</p><p><strong>(Choice B)</strong>&nbsp; This patient&#39;s laboratory work-up reveals immunity to both hepatitis A (positive IgG antibody to hepatitis A virus) and hepatitis B (positive hepatitis B surface antibody) without evidence of acute disease (negative IgM antibody to hepatitis A virus, negative hepatitis B surface antigen).&nbsp; Although acute viral hepatitis has symptom overlap with ICP (nausea, decreased appetite, elevated liver enzymes), it also presents with jaundice and malaise.&nbsp; In addition, acute viral hepatitis does not cause intense pruritus or an increased risk of IUFD.</p><p><strong>(Choice C)</strong>&nbsp; HELLP syndrome (<strong>H</strong>emolysis, <strong>E</strong>levated <strong>L</strong>iver enzymes, <strong>L</strong>ow <strong>P</strong>latelets) can present with elevated liver aminotransferases and IUFD.&nbsp; Patients with HELLP syndrome have platelet counts &#8804;100,000/mm<font size=\"2\"><sup>3</sup></font> and typically have associated hypertension, making this diagnosis less likely.</p><p><strong>(Choice E)</strong>&nbsp; Preeclampsia with severe features presents with hypertension (defined in pregnancy as systolic &#8805;140 mm Hg and/or diastolic &#8805;90 mm Hg) and elevated aminotransferases, causing IUFD due to uteroplacental insufficiency.&nbsp; This patient is normotensive, making this diagnosis unlikely.</p><p><strong>Educational objective:</strong><br>Intrahepatic cholestasis of pregnancy presents with pruritus that is worse on the hands and feet.&nbsp; Patients are at increased risk of fetal complications, including intrauterine fetal demise, particularly with markedly elevated total bile acids.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 24239,
            "topic": "Dermatoses of pregnancy",
            "titleId": 24239,
            "title": "Dermatoses of pregnancy",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "4",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute fatty liver of pregnancy",
                    "choiceNumber": 1,
                    "correctTaken": 993,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute viral hepatitis",
                    "choiceNumber": 2,
                    "correctTaken": 440,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "HELLP syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 468,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intrahepatic cholestasis of pregnancy",
                    "choiceNumber": 4,
                    "correctTaken": 3091,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preeclampsia with severe features",
                    "choiceNumber": 5,
                    "correctTaken": 31,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "237,266,true,-1,1*378,491,true,-1,1*714,1138,true,-1,1*1139,1277,true,-1,1*1454,1563,true,-1,1*1746,1803,true,-1,1*1906,2174,true,-1,1*2907,2934,true,-1,1*2956,2979,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": true,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "177",
                    "mediaDataId": 0,
                    "title": "Intrahepatic cholestasis of pregnancy",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "624",
                    "mediaDataId": 0,
                    "title": "Evaluation of abnormal liver function tests (LFTs)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26071912",
                    "mediaDataId": 0,
                    "title": "Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26071912",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30773280",
                    "mediaDataId": 0,
                    "title": "Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30773280",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 177,
            "othersAvgTimeSpent": 113,
            "notes": null,
            "peopleTaken": 5023,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1803,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 15690,
            "questionIndex": 17126,
            "questionText": "<p>A 37-year-old primigravida at 14 weeks gestation comes to the office for an initial prenatal visit.&nbsp; She has had some nausea but no vomiting, abdominal pain, or vaginal bleeding.&nbsp; The patient has type 2 diabetes mellitus and hypertension.&nbsp; She used to drink 1 or 2 glasses of wine a night but quit a year ago in anticipation of becoming pregnant.&nbsp; Temperature is 37.5 C (99.5 F), blood pressure is 138/88 mm Hg, pulse is 85/min, and respirations are 14/min.&nbsp; BMI is 36 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; On examination, the sclerae are anicteric.&nbsp; Cardiopulmonary examination is normal.&nbsp; The abdomen is nontender, and the liver edge is palpated 3 cm below the right costal margin.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>12.5 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>225,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>5,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Albumin</td><td>3.5 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td>1.0 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td>145 U/L (normal: 17-88)</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td>115 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td>125 U/L</td></tr></tbody></table><p>A right upper quadrant ultrasound reveals a hyperechoic-appearing liver, several gallstones without gallbladder wall thickening, and a normal-appearing common bile duct.&nbsp; Which of the following is the most likely cause of this patient&#39;s abnormal liver studies?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36385\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Metabolic dysfunction-associated steatotic liver disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Hepatic steatosis on imaging or biopsy</li><li>Exclusion of other etiologies (eg, alcohol, hepatitis&nbsp;C, glucocorticoids)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Mostly asymptomatic</li><li>Metabolic syndrome*</li><li>AST/ALT ratio &lt;1</li><li>Ultrasonographic findings: &uarr; echogenicity (steatosis), coarse echotexture (fibrosis)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Weight loss (eg, diet modification, exercise)</li><li>Consider bariatric surgery if BMI &ge;35 kg/m<sup>2</sup></li></ul></td></tr><tr><td><p align=\"center\"><strong>Prognosis</strong></p></td><td><ul><li>Hepatic fibrosis associated with increased risk for cirrhosis &amp; liver-related death</li></ul></td></tr><tr><td colspan=\"2\"><p>*Obesity, diabetes mellitus, dyslipidemia, hypertension.</p><p><strong>ALT</strong> = alanine aminotransferase;<strong> AST</strong> = aspartate aminotransferase.</p></td></tr></tbody></table></div><p>This patient with type 2 diabetes mellitus, obesity, and elevated aminotransferases most likely has <strong>nonalcoholic fatty liver disease</strong> (NAFLD).&nbsp; Risk factors for NAFLD include <strong>type 2 diabetes mellitus</strong>, <strong>obesity</strong>, dyslipidemia, and metabolic syndrome.&nbsp; <strong>Insulin resistance</strong> causes unregulated hepatic triglyceride synthesis, peripheral lipolysis, and free fatty acid uptake into the liver&mdash;all of which promote hepatic fat deposition (ie, hepatic steatosis).</p><p>Most patients (such as this one) are asymptomatic; some may have hepatomegaly on examination or minimal right upper quadrant pain.&nbsp; Laboratory findings include elevated aminotransferases (usually 2-5 times the upper limit of normal) with an <strong>AST/ALT ratio &lt;1</strong>.&nbsp; An ultrasound is performed to help confirm the diagnosis and usually demonstrates a <strong>hyperechoic-appearing liver</strong>, which reflects hepatic fatty infiltration.</p><p>As NAFLD progresses, steatohepatitis can occur, putting patients at risk for liver fibrosis and cirrhosis.&nbsp; The mainstay of therapy is weight loss, which can reverse NAFLD-related liver damage.</p><p><strong>(Choices A and F)</strong>&nbsp; Acute fatty liver of pregnancy (AFLP) and preeclampsia with severe features are causes of elevated aminotransferases in pregnant women.&nbsp; However, in contrast to this patient, those with AFLP or preeclampsia typically develop acute right upper quadrant pain and associated thrombocytopenia in the third trimester.</p><p><strong>(Choice B)</strong>&nbsp; Alcoholic hepatitis is characterized by AST predominance (AST/ALT ratio of 2:1) and is unlikely with light to moderate alcohol intake (&lt;15 drinks/week for men, &lt;10 drinks/week for women).</p><p><strong>(Choice C)</strong>&nbsp; Gallstones commonly develop in pregnancy because elevated progesterone levels inhibit gallbladder contraction and promote gallstone formation.&nbsp; Although gallstone formation increases the risk for cholecystitis and ascending cholangitis, patients typically have fever, leukocytosis, abdominal pain, and gallbladder wall thickening in addition to elevated aminotransferases.</p><p><strong>(Choice D)</strong>&nbsp; Intrahepatic cholestasis of pregnancy can cause elevated aminotransferase levels.&nbsp; However, patients typically have generalized pruritus that is worse on the palms and soles in addition to elevated total bilirubin levels, making this diagnosis unlikely.</p><p><strong>Educational objective:</strong><br>Nonalcoholic fatty liver disease typically presents in patients with type 2 diabetes mellitus, obesity, and elevated aminotransferases with an AST/ALT ratio &lt;1.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 9995,
            "topic": "Nonalcoholic fatty liver disease",
            "titleId": 9995,
            "title": "Nonalcoholic fatty liver disease",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute fatty liver of pregnancy",
                    "choiceNumber": 1,
                    "correctTaken": 2501,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Alcoholic hepatitis",
                    "choiceNumber": 2,
                    "correctTaken": 175,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gallstone disease",
                    "choiceNumber": 3,
                    "correctTaken": 1431,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intrahepatic cholestasis of pregnancy",
                    "choiceNumber": 4,
                    "correctTaken": 5683,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonalcoholic fatty liver disease",
                    "choiceNumber": 5,
                    "correctTaken": 6374,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preeclampsia",
                    "choiceNumber": 6,
                    "correctTaken": 231,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "814,1017,true,-1,1*1177,1277,true,-1,1*1542,1627,true,-1,1*1793,1959,true,-1,1*2106,2158,true,-1,1*2172,2314,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28714183",
                    "mediaDataId": 0,
                    "title": "The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28714183",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 145,
            "othersAvgTimeSpent": 84,
            "notes": null,
            "peopleTaken": 16395,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 39,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1306,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 16416,
            "questionIndex": 17860,
            "questionText": "<p>A 41-year-old man comes to the office due to progressive abdominal distension for the past 3 months.&nbsp; He states that his abdomen feels heavy and although uncomfortable, the feeling has not been severe enough to interfere with activities of daily living.&nbsp; The patient drinks 8-10 beers a day and was hospitalized for alcoholic hepatitis 2 years ago.&nbsp; Vital signs are within normal limits.&nbsp; BMI is 26 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows no jaundice.&nbsp; Heart and lung sounds are unremarkable.&nbsp; The abdomen is soft with mildly tender liver edge palpable at the right costal margin.&nbsp; There is no extremity edema.&nbsp; Abdominal ultrasonography demonstrates nodular liver with coarse echotexture and ascites.&nbsp; Which of the following would most significantly decrease both liver inflammation and portal pressure in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has developed ascites likely due to chronic liver disease, as suggested by ultrasonography findings of liver nodularity and coarse echotexture.&nbsp; His heavy alcohol intake of 8-10 beers a day makes <strong>alcohol-associated liver disease</strong> (AALD) the most likely etiology.&nbsp; AALD includes (acute) alcoholic hepatitis and a spectrum of chronic conditions (eg, steatosis, steatohepatitis, cirrhosis).</p><p>In AALD, chronic and heavy alcohol use serves as a hepatic insult that can cause steatosis (ie, fatty liver), which can lead to steatohepatitis (ie, <strong>inflammation</strong>).&nbsp; Sustained inflammation activates hepatic stellate cells, which trigger fibrogenesis.&nbsp; <strong>Fibrosis</strong> can eventually <strong>progress to cirrhosis</strong>, characterized histologically by the formation of regenerative nodules surrounded by <a href=\"46965\">fibrous bands</a> and accompanied clinically by <strong>high portal pressure</strong> and its complications (eg, ascites, esophageal varices).</p><p>Early cirrhosis can coexist with ongoing inflammation and fibrogenesis, which are both potentially reversible processes.&nbsp; In patients with AALD, <strong>complete alcohol cessation</strong> can <strong>decrease hepatic inflammation</strong>, fibrogenesis, and <strong>portal pressure</strong>; as such, a survival benefit can be seen compared to patients who continue to consume alcohol.</p><p>In contrast, once end-stage cirrhosis develops, the benefits from alcohol cessation become less impactful.</p><p><strong>(Choice A)</strong>&nbsp; ACE inhibitors are typically avoided in cirrhosis due to a high risk of hypotension because these medications blunt the renin-angiotensin-aldosterone system, which serves to maintain normotension (ie, counteracting splanchnic vasodilation).&nbsp; ACE inhibitors may theoretically reduce hepatic inflammation and portal pressure, but these effects are not nearly as impactful as removal of the hepatic insult (eg, alcohol cessation).</p><p><strong>(Choice B)</strong>&nbsp; Nonselective beta blockers (eg, nadolol) reduce portal pressure and are therefore used to prevent bleeding in patients with esophageal varices.&nbsp; Beta blockers may also slightly lower systemic markers of inflammation, but it is unclear whether this translates into decreased liver inflammation.</p><p><strong>(Choice D)</strong>&nbsp; Diuretics (eg, spironolactone, furosemide) induce natriuresis and can reduce portal pressure, thereby helping treat ascites.&nbsp; However, diuretics would not be expected to significantly reverse hepatic inflammation.</p><p><strong>(Choice E)</strong>&nbsp; Ursodeoxycholic acid is used in primary biliary cholangitis to decrease hepatic accumulation of toxic bile acids, thereby reducing hepatic inflammation and portal pressure.&nbsp; Ursodeoxycholic acid is not effective for AALD.</p><p><strong>Educational objective:</strong><br>In patients with alcohol-associated liver disease, complete alcohol cessation significantly reduces liver inflammation, fibrosis, and portal pressure.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 2874,
            "topic": "Cirrhosis",
            "titleId": 2874,
            "title": "Cirrhosis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "ACE inhibitor therapy",
                    "choiceNumber": 1,
                    "correctTaken": 345,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Beta blocker therapy",
                    "choiceNumber": 2,
                    "correctTaken": 1115,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Complete alcohol cessation",
                    "choiceNumber": 3,
                    "correctTaken": 8405,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diuretic therapy",
                    "choiceNumber": 4,
                    "correctTaken": 1652,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ursodeoxycholic acid therapy",
                    "choiceNumber": 5,
                    "correctTaken": 274,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "934,1053,true,-1,1*1270,1376,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "355",
                    "mediaDataId": 0,
                    "title": "Complications of cirrhosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "34068269",
                    "mediaDataId": 0,
                    "title": "Alcohol-related liver disease: basic mechanisms and clinical perspectives",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/34068269",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 97,
            "othersAvgTimeSpent": 45,
            "notes": null,
            "peopleTaken": 11791,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 739,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 4625,
            "questionIndex": 4625,
            "questionText": "<p>A 56-year-old man is brought to the emergency department due to worsening confusion.&nbsp; He has been forgetful and irritable for the past several days, and today, the patient&#39;s wife found him in bed, lethargic and disoriented.&nbsp; He has had no fever, headache, abdominal pain, or vomiting.&nbsp; The patient drinks a half to a full pint of vodka daily and was hospitalized previously for acute alcoholic pancreatitis.&nbsp; Temperature is 36.9 C (98.4 F), blood pressure is 116/68 mm Hg, and pulse is 84/min.&nbsp; The patient is somnolent but awakens to physical stimuli.&nbsp; He follows simple instructions but is not oriented to time or place.&nbsp; His speech is slurred.&nbsp; Lung fields are clear to auscultation and cardiac examination reveals normal heart sounds with no murmur.&nbsp; The abdomen is moderately distended with shifting dullness.&nbsp; The patient moves all extremities equally and has a flapping tremor of his outstretched, dorsiflexed hands.&nbsp; Deep tendon reflexes are 3+ diffusely.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hematocrit</td><td>32%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>110,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>4,100 /mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>132 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>3.8 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td>28 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>0.8 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>140 mg/dL</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Albumin</td><td>2.8 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td>170 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase</td><td>97 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase</td><td>46 U/L</td></tr></tbody></table><p>Which of the following treatments will most likely improve this patient&#39;s mental status?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34440\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hepatic encephalopathy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Precipitating factors</strong></p></td><td><ul><li>Drugs (eg, sedatives, narcotics)</li><li>Hypovolemia (eg, diarrhea)</li><li>Electrolyte changes (eg, hypokalemia)</li><li>&uarr; Nitrogen load (eg, GI bleeding)</li><li>Infection (eg, pneumonia, UTI, SBP)</li><li>Portosystemic shunting (eg, TIPS)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Sleep pattern changes</li><li>Altered mental status</li><li>Ataxia</li><li>Asterixis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Correct precipitating causes (eg, fluids, antibiotics)</li><li>&darr; Blood ammonia concentration (eg, lactulose, rifaximin)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>GI</strong>&nbsp;=&nbsp;gastrointestinal; <strong>SBP</strong>&nbsp;=&nbsp;spontaneous bacterial peritonitis; <strong>TIPS</strong>&nbsp;=&nbsp;transjugular intrahepatic portosystemic shunt; <strong>UTI</strong>&nbsp;=&nbsp;urinary tract infection.</p></td></tr></tbody></table></div><p>This patient with likely cirrhosis (heavy alcohol use, ascites, thrombocytopenia) now has progressive confusion, slurred speech, and asterixis (flapping tremor with outstretched hands), which is suggestive of <strong>hepatic encephalopathy (HE)</strong>.&nbsp; HE refers to impaired central nervous system function in patients with cirrhosis and is due in part to ammonia neurotoxicity from impaired liver function.&nbsp; Treatment involves identifying any <strong>underlying precipitant</strong> (eg, infection, sedative medications, gastrointestinal bleed) and lowering <strong>serum ammonia</strong>.</p><p><strong>Nonabsorbable disaccharides (eg, lactulose, lactitol)</strong> are preferred for lowering serum ammonia.&nbsp; Colonic bacteria metabolize lactulose to short-chain fatty acids (eg, lactic acid, acetic acid).&nbsp; This acidifies the colon to stimulate conversion of the absorbable ammonia to the nonabsorbable ammonium (an ammonia trap) and causes bowel movements (which facilitates fecal nitrogen excretion).&nbsp; The medication is titrated to produce 2 or 3 semiformed stools daily.</p><p><strong>(Choice A)</strong>&nbsp; Broad-spectrum antibiotics would be appropriate in a patient with a suspected or confirmed infection, which would generally present with fever, elevated leukocyte count, and other signs of infection (eg, tachycardia).</p><p><strong>(Choice B)</strong>&nbsp; Chlordiazepoxide is a long-acting benzodiazepine used to treat alcohol withdrawal, which would usually cause autonomic instability (eg, tachycardia, hypertension) along with mental status changes.</p><p><strong>(Choice C)</strong>&nbsp; Dantrolene is used in neuroleptic malignant syndrome and malignant hyperthermia.&nbsp; Patients with these conditions usually have severe muscle rigidity, fever, and tachycardia.</p><p><strong>(Choice D)</strong>&nbsp; Hypertonic saline is usually used in patients with hyponatremia and severe symptoms (eg, coma, seizure).&nbsp; A serum sodium level of 132 mg/dL is mild hyponatremia, which is not uncommon in patients with cirrhosis (hypervolemic hyponatremia) and would be an unlikely cause of this patient&#39;s symptoms.</p><p><strong>(Choice E)</strong>&nbsp; Thiamine is used to treat and prevent Wernicke encephalopathy, which may be seen in alcoholics due to poor dietary intake of thiamine.&nbsp; It presents as altered mental status, ataxia, and nystagmus, but asterixis is not generally present.</p><p><strong>(Choice G)</strong>&nbsp; A high-protein diet is generally not recommended in patients with cirrhosis as it can precipitate HE by causing increased serum ammonia levels.</p><p><strong>Educational objective:</strong><br>Treatment of hepatic encephalopathy involves identifying the underlying precipitant and lowering serum ammonia.&nbsp; Nonabsorbable disaccharides (eg, lactulose, lactitol) are preferred for lowering serum ammonia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 1625,
            "topic": "Hepatic Encephalopathy",
            "titleId": 1625,
            "title": "Hepatic Encephalopathy",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Initiate broad-spectrum antibiotics",
                    "choiceNumber": 1,
                    "correctTaken": 133,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate chlordiazepoxide",
                    "choiceNumber": 2,
                    "correctTaken": 333,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate dantrolene",
                    "choiceNumber": 3,
                    "correctTaken": 53,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate hypertonic saline",
                    "choiceNumber": 4,
                    "correctTaken": 353,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate intravenous thiamine",
                    "choiceNumber": 5,
                    "correctTaken": 2693,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate lactulose",
                    "choiceNumber": 6,
                    "correctTaken": 12920,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe a high-protein diet",
                    "choiceNumber": 7,
                    "correctTaken": 21,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1174,1635,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25042402",
                    "mediaDataId": 0,
                    "title": "Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25042402",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 162,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 16506,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 875,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 15012,
            "questionIndex": 16436,
            "questionText": "<p>A 65-year-old man has a cardiac arrest in a shopping mall.&nbsp; Resuscitation is initiated in the field, and the patient is successfully defibrillated.&nbsp; In the emergency department, he is found to have ST segment elevations in the inferior leads and then has an episode of sustained ventricular tachycardia that is treated with intravenous amiodarone.&nbsp; The patient is taken to the cardiac catheterization lab and is found to have a thrombotic occlusion of the right coronary artery, which is successfully treated with percutaneous coronary intervention.&nbsp; On the second day of hospitalization he demonstrates full neurologic recovery and is asymptomatic.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Albumin</td><td>3.8 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td>1.3 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td>114 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td>1355 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td>1124 U/L</td></tr></tbody></table><p>The patient&#39;s laboratory results were within normal limits 1 week prior to admission.&nbsp; Which of the following is the most likely cause of the new findings?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has developed <strong>ischemic hepatitis</strong> (shock liver) resulting from <strong>myocardial infarction</strong>, ventricular tachycardia, and <strong>cardiogenic shock</strong>.&nbsp; Ischemic hepatitis usually occurs in the setting of global hypoperfusion and/or hypoxemia; in addition to cardiac insults, other common causes include hypovolemic and septic shock as well as respiratory failure.&nbsp; Histologically, <strong>hepatocyte necrosis</strong> is found predominantly in <a href=\"21268\">zone 3</a> of the liver lobule, ie, surrounding the central veins where cells are farthest from the oxygen supply coming from the hepatic artery (~40% of the liver&#39;s oxygen supply) and the portal vein (~60% of the liver&#39;s oxygen supply as partially deoxygenated blood).</p><p>Patients often develop <strong>aminotransferase levels &gt;1000 U/L</strong> shortly after the inciting incident.&nbsp; Although the bilirubin level can be unaffected, it usually rises several days later.&nbsp; Prognosis is poor as patients are typically critically ill and often have accompanying multiorgan failure.&nbsp; In those who survive, the hepatic injury tends to be self-limited; aminotransferase elevations usually resolve within 7 days, and bilirubin levels normalize over the course of several weeks.</p><p><strong>(Choice A)</strong>&nbsp; Acalculous cholecystitis usually occurs as a complication of shock or other critical illness.&nbsp; Mild elevations in total bilirubin, alkaline phosphatase, and aminotransferases are typical; however, aminotransferase elevation &gt;1000 U/L would not be consistent.</p><p><strong>(Choice B)</strong>&nbsp; Like ischemic hepatitis, acute viral hepatitis can cause elevations in aminotransferases &gt;1000 U/L, most commonly from acute infection with hepatitis A or B.&nbsp; Acute hepatitis A, which is transmitted fecal-orally, tends to present with fever, nausea, and vomiting.&nbsp; Patients with acute hepatitis B often have identifiable risk factors, including intravenous drug use, recent blood transfusions, or unprotected sexual intercourse.</p><p><strong>(Choice D)</strong>&nbsp; This patient was exposed to amiodarone, which can cause hepatic steatosis and cholestasis.&nbsp; This would cause a rise in bilirubin, but marked aminotransferase elevations &gt;1000 U/L are not typical.&nbsp; Acute liver failure due to amiodarone toxicity is rare.</p><p><strong>(Choice E)</strong>&nbsp; Aspartate aminotransferase (AST) is present in cardiac myocytes, skeletal myocytes, and intestinal smooth muscle, and serum levels can rise following injury to any of these tissues.&nbsp; However, alanine aminotransferase (ALT) is specific to hepatocytes and would not increase in the absence of hepatic injury.</p><p><strong>Educational objective:</strong><br>Ischemic hepatitis, characterized histologically by zone 3-predominant hepatocyte necrosis, occurs in the setting of global hypoperfusion and/or hypoxemia.&nbsp; Common causes include cardiac insults (eg, myocardial infarction, unstable arrythmias), respiratory failure, hypovolemia, and septic shock.&nbsp; Patients immediately develop severe aminotransferase elevations with bilirubin levels remaining unaffected or rising a few days later.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 12508,
            "topic": "Ischemic hepatitis",
            "titleId": 12508,
            "title": "Ischemic hepatitis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acalculous cholecystitis",
                    "choiceNumber": 1,
                    "correctTaken": 408,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute viral hepatitis",
                    "choiceNumber": 2,
                    "correctTaken": 540,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatocyte ischemia",
                    "choiceNumber": 3,
                    "correctTaken": 9961,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication-induced liver injury",
                    "choiceNumber": 4,
                    "correctTaken": 6244,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Muscle injury",
                    "choiceNumber": 5,
                    "correctTaken": 483,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "176,389,true,-1,1*406,448,true,-1,1*458,478,true,-1,1*2186,2493,true,-1,1*2739,2781,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26587034",
                    "mediaDataId": 0,
                    "title": "Hepatic shock differential diagnosis and risk factors: a review article.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26587034",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 102,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 17636,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 902,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 14719,
            "questionIndex": 16137,
            "questionText": "<p>A 37-year-old woman, gravida 1 para 0, at 34 weeks gestation comes to the emergency department due to nausea, vomiting, and severe epigastric pain.&nbsp; The patient first noticed the pain after breakfast yesterday.&nbsp; The pain continued throughout the day and now involves the right upper quadrant.&nbsp; She has been taking acetaminophen with no pain relief.&nbsp; The patient developed nausea and recurrent vomiting 4 hours ago.&nbsp; She has not had routine prenatal care.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 130/80 mm Hg, and pulse is 106/min.&nbsp; Fetal heart rate monitoring shows a baseline of 170/min with minimal variability.&nbsp; No contractions are shown on the tocodynamometer.&nbsp; There is tenderness to palpation over the epigastrium and right upper quadrant, with no rebound or guarding.&nbsp; The uterus is nontender.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Hemoglobin</td><td style=\"vertical-align:middle;\">10 g/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\"> Platelets</td><td style=\"vertical-align:middle;\">80,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\"> Leukocytes</td><td style=\"vertical-align:middle;\">18,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\"> Creatinine</td><td style=\"vertical-align:middle;\">0.8 mg/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\"> Glucose</td><td style=\"vertical-align:middle;\">40 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Total bilirubin</td><td style=\"vertical-align:middle;\">4 mg/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">103 U/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\"> Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">96 U/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\"> Amylase</td><td style=\"vertical-align:middle;\">130 U/L (3rd trimester normal: 20-96)</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\"> Lipase</td><td style=\"vertical-align:middle;\">42 U/L (3rd trimester normal: 41-112)</td></tr></tbody></table><p>Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T49138\" style=\"overflow-x:auto;\" tid=\"22799\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Acute fatty liver of pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Nausea, vomiting</li><li>Right upper quadrant/epigastric pain</li><li>Fulminant liver failure</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Profound hypoglycemia</li><li>&#8593; Aminotransferases (2-3&times; normal)</li><li>&#8593; Bilirubin</li><li>Thrombocytopenia</li><li>Disseminated intravascular coagulopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Immediate delivery</li></ul></td></tr></tbody></table></div><p>This patient has <strong>acute fatty liver of pregnancy</strong> (AFLP), a rare but life-threatening condition that typically develops in the third trimester.&nbsp; Like other disorders that affect the liver during pregnancy (eg, preeclampsia, HELLP syndrome [<strong>H</strong>emolysis, <strong>E</strong>levated <strong>L</strong>iver enzymes, and <strong>L</strong>ow <strong>P</strong>latelet count]), AFLP causes hepatic inflammation that leads to <strong>right upper quadrant pain</strong>, leukocytosis, and <strong>mildly elevated aminotransferases</strong>.</p><p>However, AFLP is unique because it is an intrahepatic process due to microvesicular fatty infiltration of hepatocytes secondary to abnormal maternal-fetal fatty acid metabolism.&nbsp; This massive intrahepatic injury results in acute-onset <strong>fulminant liver failure</strong> that manifests as <strong>profound hypoglycemia</strong> (from inability to convert glycogen to glucose).&nbsp; Laboratory evidence of hypoglycemia helps distinguish AFLP from other pregnancy-related disorders that affect the liver (eg, HELLP syndrome) because there is overlap in other laboratory values, such as elevated aminotransferases, hyperbilirubinemia, and <strong>thrombocytopenia</strong> (&lt;100,000/mm<font size=\"2\"><sup>3</sup></font>).</p><p>Patients develop rapid decompensation, multiorgan failure (eg, hemolytic anemia, kidney failure), and possible disseminated intravascular coagulation; this in turn can cause placental hypoperfusion and fetal compromise (eg, fetal tachycardia, minimal variability).&nbsp; Due to high maternal and fetal mortality rates, management is <strong>immediate delivery</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Acetaminophen toxicity can cause fulminant liver failure; however, it typically causes markedly elevated aminotransferases (eg, &gt;3,000 U/L), which are not seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Pregnancy is a risk factor for acute cholecystitis, which can present with postprandial right upper quadrant pain and elevated aminotransferases.&nbsp; However, acute cholecystitis typically does not cause fulminant liver failure (indicated by hypoglycemia and thrombocytopenia).</p><p><strong>(Choice D)</strong>&nbsp; Acute pancreatitis can present with persistent vomiting, severe epigastric pain, leukocytosis, and elevated amylase and lipase levels.&nbsp; This patient has an elevated amylase (but normal lipase) level, likely from vomiting.&nbsp; A normal lipase level and right upper quadrant pain are not consistent with pancreatitis.</p><p><strong>(Choice E)</strong>&nbsp; Preeclampsia with severe features can present in the third trimester with right upper quadrant pain, elevated aminotransferases, and thrombocytopenia due to end-organ damage from hypertension (ie, systolic &#8805;140 mm Hg or diastolic &#8805;90 mm Hg in a pregnant patient).&nbsp; This patient is normotensive, making preeclampsia less likely.</p><p><strong>Educational objective:</strong><br>Acute fatty liver of pregnancy typically occurs in the third trimester due to microvesicular fatty infiltration of hepatocytes, leading to liver inflammation (eg, right upper quadrant pain, elevated aminotransferases) and fulminant liver failure (eg, profound hypoglycemia, thrombocytopenia).&nbsp; Management is immediate delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 5164,
            "topic": "Acute fatty liver of pregnancy",
            "titleId": 5164,
            "title": "Acute fatty liver of pregnancy",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acetaminophen toxicity",
                    "choiceNumber": 1,
                    "correctTaken": 68,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute cholecystitis",
                    "choiceNumber": 2,
                    "correctTaken": 1126,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute fatty liver of pregnancy",
                    "choiceNumber": 3,
                    "correctTaken": 2650,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute pancreatitis",
                    "choiceNumber": 4,
                    "correctTaken": 676,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preeclampsia with severe features",
                    "choiceNumber": 5,
                    "correctTaken": 491,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "758,1056,true,-1,1*1106,1393,true,-1,1*1394,1741,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "169",
                    "mediaDataId": 0,
                    "title": "Acute fatty liver of pregnancy",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28291236",
                    "mediaDataId": 0,
                    "title": "Acute fatty liver disease of pregnancy: updates in pathogenesis, diagnosis, and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28291236",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26658682",
                    "mediaDataId": 0,
                    "title": "Pregnancy and liver disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26658682",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 165,
            "othersAvgTimeSpent": 113,
            "notes": null,
            "peopleTaken": 5011,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 926,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 17239,
            "questionIndex": 18691,
            "questionText": "<p>A 47-year-old woman comes to the emergency department due to jaundice.&nbsp; It started 3 days ago and is associated with fatigue, nausea, and itchiness but not confusion or drowsiness.&nbsp; Medical history is significant for celiac disease.&nbsp; The patient takes no prescription or over-the-counter medications.&nbsp; She rarely drinks alcohol and does not use illicit drugs.&nbsp; Family history is unremarkable.&nbsp; Temperature is 37.6 C (99.7 F), blood pressure is 125/80 mm Hg, pulse is 80/min, and respiratory rate is 12/min.&nbsp; Physical examination reveals scleral icterus.&nbsp; Cardiopulmonary examination is unremarkable.&nbsp; Asterixis is absent.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">14.2 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">85,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">7,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td style=\"vertical-align:middle;\">4.2 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td style=\"vertical-align:middle;\">210 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">842 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">876 U/L</td></tr></tbody></table><p>Anti&ndash;smooth muscle antibody and antinuclear antibody titers are both markedly elevated.&nbsp; Which of the following would be the best next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t58632\"><table class=\"table-default-style table-header-footer-style\" style=\"width:85.66%\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Autoimmune hepatitis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Presentation</strong></p></td><td><ul><li>Asymptomatic</li><li>Symptomatic (eg, anorexia, nausea, abdominal pain, jaundice)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br>findings</strong></p></td><td><ul><li>Hepatocellular pattern (&#8593;&#8593;&nbsp;AST &amp; ALT, &plusmn;&nbsp;mildly elevated alkaline phosphatase &amp;&nbsp;total bilirubin)</li><li>Hypergammaglobulinemia with elevated gamma gap</li><li>Elevated anti&ndash;smooth muscle autoantibodies</li></ul></td></tr><tr><td><p align=\"center\"><strong>Histology</strong></p></td><td><ul><li>Portal &amp; periportal lymphoplasmacytic infiltration</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALT</strong>&nbsp;=&nbsp;alanine aminotransferase; <strong>AST</strong>&nbsp;=&nbsp;aspartate aminotransferase.</p></td></tr></tbody></table></div><p>This patient with fatigue, pruritus, jaundice, and elevated liver enzymes and autoantibody titers (ie, anti&ndash;smooth muscle, antinuclear) has <strong>autoimmune hepatitis</strong> (AIH).&nbsp; AIH is a chronic liver disease that occurs most commonly in middle-aged <strong>women</strong> with comorbid autoimmune disease (eg, autoimmune thyroiditis).</p><p>The initial presentation of AIH is variable, ranging from asymptomatic laboratory abnormalities to cirrhosis or acute liver failure.&nbsp; However, most patients have constitutional symptoms (eg, fatigue, weight loss, nausea), abdominal discomfort, <strong>pruritus</strong>, and <strong>jaundice</strong>.&nbsp; Laboratory evaluation typically demonstrates a <strong>hepatocellular pattern</strong> of liver injury with predominant elevations in transaminases (up to 20x the upper limit of normal) with variable elevations of bilirubin.</p><p>A variety of autoantibodies occur with AIH, leading to hypergammaglobulinemia and an elevated gamma gap (total protein &#8722; albumin = &gt;4 g/dL).&nbsp; <strong>Antinuclear antibody</strong> is the most common antibody; however, the presence of <strong>anti&ndash;smooth muscle antibody</strong> is more specific for AIH.&nbsp; Management includes immunosuppression with <strong>glucocorticoids</strong> (eg, prednisone) with or without azathioprine.</p><p><strong>(Choice A)</strong>&nbsp; N-acetylcysteine is used to treat acetaminophen overdose, which also presents with a hepatocellular patten of liver injury; however, elevated autoantibodies are unexpected.&nbsp; Furthermore, acetaminophen toxicity is typically more rapidly progressive, with markedly elevated transaminases (eg, &gt;10,000 U/L) and hepatic failure (eg, asterixis, encephalopathy) occurring at ~72 hours.&nbsp; Pruritus and less significant transaminase elevations are more consistent with AIH.</p><p><strong>(Choice B)</strong>&nbsp; Patients with AIH but without evidence of active inflammation (eg, normal aminotransferases, normal gamma globulin levels, minimal inflammatory changes on liver biopsy) can be observed without therapy; however, this symptomatic patient requires immunosuppression.</p><p><strong>(Choice D)</strong>&nbsp; Liver transplant should be considered for patients with acute liver failure (ie, hepatic encephalopathy, prolonged PT, elevated transaminases) or decompensated cirrhosis (eg, ascites, variceal hemorrhage).&nbsp; Although transplantation could be considered if the patient&#39;s condition decompensates, immunosuppression may obviate this need in the future.</p><p><strong>(Choice E)</strong>&nbsp; Ursodeoxycholic acid is used to treat primary biliary cholangitis, an autoimmune disorder characterized by a cholestatic pattern of liver injury (predominant elevations in alkaline phosphatase) and antimitochondrial antibody titers.&nbsp; This patient&#39;s hepatocellular pattern of injury and positive anti&ndash;smooth muscle antibody are more consistent with AIH.</p><p><strong>Educational objective:</strong><br>Autoimmune hepatitis is characterized by a hepatocellular pattern of liver injury with increased autoantibody titers (eg, anti&ndash;smooth muscle, antinuclear) and hypergammaglobulinemia.&nbsp; Typical manifestations include nausea, fatigue, pruritus, and jaundice.&nbsp; The mainstay of treatment is prednisone with or without azathioprine.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 1468,
            "topic": "Autoimmune hepatitis",
            "titleId": 1468,
            "title": "Autoimmune hepatitis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "N-acetylcysteine",
                    "choiceNumber": 1,
                    "correctTaken": 208,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observation",
                    "choiceNumber": 2,
                    "correctTaken": 190,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prednisone",
                    "choiceNumber": 3,
                    "correctTaken": 10312,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Referral for liver transplantation",
                    "choiceNumber": 4,
                    "correctTaken": 1199,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ursodeoxycholic acid",
                    "choiceNumber": 5,
                    "correctTaken": 4624,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "254,300,true,-1,1*354,404,true,-1,1*1258,1399,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "357",
                    "mediaDataId": 0,
                    "title": "Autoimmune hepatitis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "624",
                    "mediaDataId": 0,
                    "title": "Evaluation of abnormal liver function tests (LFTs)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 79,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 16533,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 985,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 2977,
            "questionIndex": 2977,
            "questionText": "<p>A 26-year-old woman comes to the office due to yellowish discoloration of the eyes and dark urine for the past several days.&nbsp; She has no abdominal pain, anorexia, or nausea.&nbsp; The patient has been told a few times that her eyes look yellow in the past.&nbsp; She has no significant medical history other than mild acne vulgaris.&nbsp; The patient started taking oral contraceptives 2 weeks ago.&nbsp; Her father has diabetes mellitus, and her grandfather has heart failure.&nbsp; The patient is a doctoral student and moved to the United States from abroad a year ago.&nbsp; Vitals signs are normal.&nbsp; Examination shows mild scleral icterus.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td style=\"vertical-align:middle;\">4.1 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td style=\"vertical-align:middle;\">61 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">32 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">28 U/L</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Urinalysis</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Bilirubin</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Urobilinogen</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>During further evaluation, the sample from a liver biopsy shows dark, granular pigments in the hepatocytes.&nbsp; Which of the following is the most likely cause of this patient&#39;s current condition?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"7027\" src=\"https://www.uworld.com/media/L13480.jpg\" ></p><p>This patient with scleral icterus and hyperbilirubinemia has a positive urine bilirubin assay.&nbsp; In contrast to unconjugated bilirubin (water insoluble), conjugated bilirubin (water soluble) can be excreted through the urine, making this patient&#39;s findings consistent with <strong>conjugated</strong> (direct) hyperbilirubinemia.&nbsp; Her <strong>intermittent</strong> symptoms and <strong>otherwise normal liver function</strong> tests suggest <strong>benign hereditary hyperbilirubinemia</strong>.</p><p>This patient has <a href=\"6598\">Dubin-Johnson syndrome</a>, a rare condition caused by a <strong>defect</strong> in a hepatocyte transporter protein responsible for bilirubin excretion into the <a href=\"1741\">biliary system</a>.&nbsp; <strong>Impaired hepatic excretion of conjugated bilirubin</strong> results in chronic or fluctuating direct hyperbilirubinemia and bilirubinuria (ie, dark urine).&nbsp; <strong>Episodes of scleral icterus</strong> typically begin in puberty or early adulthood and are provoked by illness, pregnancy, or oral contraceptive use, the likely trigger in this patient.</p><p>Although not required for the diagnosis, liver biopsy would show a grossly black liver and <strong>dark, granular pigment</strong> accumulation within <strong>hepatocytes</strong>, which differentiates this syndrome from other benign hereditary causes of conjugated hyperbilirubinemia in which biopsies are normal (eg, Rotor syndrome).&nbsp; Dubin-Johnson syndrome has no long-term sequelae, and treatment is not required.</p><p><strong>(Choice A)</strong>&nbsp; Choledocholithiasis causing bile duct obstruction presents with abdominal pain, nausea, and vomiting, findings not seen in this patient.&nbsp; In addition, direct bilirubin as well as alkaline phosphatase would be elevated; liver biopsy may show portal tract inflammation but not granular hepatocyte deposits.</p><p><strong>(Choices B and C)</strong>&nbsp; Gilbert syndrome (ie, decreased bilirubin glucuronidation) and intravascular hemolysis (eg, autoimmune hemolytic anemia) can present with episodic jaundice due to elevated unconjugated (indirect) bilirubin, which is metabolized to urobilinogen for urinary excretion (ie, positive urobilinogen on urinalysis).&nbsp; Bilirubin would not be present in the urine, and liver biopsy would be normal.</p><p><strong>(Choice D)</strong>&nbsp; Although conjugated hyperbilirubinemia may occur in hereditary hemochromatosis (eg, hepatic iron overload), this condition more commonly causes elevated transaminases, and other disease manifestations, including fatigue, hyperpigmentation, arthralgias, and diabetes, are usually present.&nbsp; Moreover, presentation in most women occurs after menopause because menstrual blood loss typically prevents excessive iron accumulation.</p><p><strong>(Choice F)</strong>&nbsp; Jaundice due to viral hepatitis is usually accompanied by fatigue, nausea, and right upper quadrant pain.&nbsp; In addition, transaminases would be significantly elevated, and liver biopsy would show hepatocyte injury and/or fibrosis rather than granular hepatocyte deposits.</p><p><strong>Educational objective:</strong><br>Intermittent scleral icterus and conjugated hyperbilirubinemia with otherwise normal liver function tests suggest benign hereditary hyperbilirubinemia (eg, Dubin-Johnson syndrome).&nbsp; This condition impairs hepatic excretion of conjugated bilirubin and is characterized by dark granular pigments within hepatocytes on histopathology.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 25257,
            "topic": "Jaundice",
            "titleId": 25257,
            "title": "Jaundice",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Common bile duct obstruction",
                    "choiceNumber": 1,
                    "correctTaken": 236,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased bilirubin glucuronidation",
                    "choiceNumber": 2,
                    "correctTaken": 4728,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Episodic intravascular hemolysis",
                    "choiceNumber": 3,
                    "correctTaken": 929,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatic iron overload",
                    "choiceNumber": 4,
                    "correctTaken": 2138,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Impaired hepatocyte bilirubin excretion",
                    "choiceNumber": 5,
                    "correctTaken": 8398,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Viral hepatocyte infection",
                    "choiceNumber": 6,
                    "correctTaken": 177,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "632,957,true,-1,1*959,1341,true,-1,1*1573,1659,true,-1,1*1842,1986,true,-1,1*2712,2788,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26595536",
                    "mediaDataId": 0,
                    "title": "Inherited disorders of bilirubin clearance.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26595536",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 61,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 16606,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 51,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1575,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 4602,
            "questionIndex": 4602,
            "questionText": "<p>A 53-year-old woman comes to the office due to progressive exertional dyspnea over the past several weeks.&nbsp; During this time, the patient&#39;s abdominal girth has also increased, with associated discomfort and early satiety.&nbsp; Medical history is significant for bacterial endocarditis due to intravenous drug use.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 120/70 mm Hg, pulse is 85/min, and respirations are 18/min.&nbsp; Physical examination shows no jugular venous distension or hepatojugular reflux.&nbsp; The chest is clear to auscultation.&nbsp; The abdomen is distended and nontender.&nbsp; Both shifting dullness and a fluid wave are present.&nbsp; Hepatosplenomegaly is present.&nbsp; There is trace bilateral lower extremity edema.&nbsp; Which of the following best explains this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"3269\" src=\"https://www.uworld.com/media/highresdefault/L25246.jpg\"  ></p><p>This patient with progressive dyspnea has <strong>ascites</strong> (ie, abdominal distension, shifting dullness, fluid wave).&nbsp; Although ascites can occur from a variety of diseases, over 80% of cases are due to <strong>cirrhosis</strong> (ie, chronic liver disease).&nbsp; Common causes include chronic hepatitis infection (the most likely etiology in this patient with intravenous drug use), heavy alcohol use, and nonalcoholic fatty liver disease.</p><p>Cirrhosis is characterized by <a href=\"32775\">portal hypertension</a>, which causes hemodynamic changes (ie, splanchnic vasodilation) that lead to salt and water retention (eg, edema, ascites).&nbsp; Signs and symptoms of ascites include <strong>increased abdominal girth</strong> with weight gain, early satiety, and dyspnea (due to impaired diaphragmatic excursion).&nbsp; Physical examination shows <strong>shifting dullness</strong> and a <strong>fluid wave</strong>.&nbsp; Abdominal ultrasonography can confirm the presence of ascites.&nbsp; <a href=\"66656\">Diagnostic paracentesis</a> with calculation of the serum-to-ascites albumin gradient can distinguish between portal hypertensive and non&ndash;portal hypertensive causes.</p><p>Although cirrhosis is associated with a shrunken liver and <strong>splenomegaly</strong> (congestion from portal hypertension), hepatomegaly (vs shrunken liver) can occasionally be seen in early cirrhosis due to ongoing inflammation; the classic stigmata of chronic liver disease (eg, spider angiomas, palmar erythema, jaundice) may not yet be present.</p><p><strong>(Choices B and E)</strong>&nbsp; Both constrictive pericarditis and right-sided heart failure (eg, from tricuspid valve endocarditis) may cause ascites and hepatosplenomegaly due to portal hypertension.&nbsp; However, jugular venous distension (JVD) is expected (eg, <a href=\"51532\">hepatojugular reflux</a>), and Kussmaul sign (ie, rise in JVD with inspiration) may be present.&nbsp; In addition, constrictive pericarditis, which can be idiopathic/viral, usually presents with a pericardial knock (accentuated heart sound before S3, seen in ~50% of cases) and pulsus paradoxus (less common than in cardiac tamponade).</p><p><strong>(Choice C)</strong>&nbsp; Nephrotic syndrome presents with massive peripheral edema (vs trace edema in this patient) and ascites due to profound hypoalbuminemia.&nbsp; Because portal pressure is unaffected in nephrotic syndrome, hepatosplenomegaly is not expected.</p><p><strong>(Choice D)</strong>&nbsp; Ovarian cancer with peritoneal metastasis (ie, carcinomatosis) can cause ascites without portal hypertension; therefore, hepatosplenomegaly is not typical.&nbsp; Moreover, patients usually have abdominal pain from tumor invasion, in addition to either weight loss or no change in weight (eg, weight gain from ascites offsets weight loss from cancer cachexia).</p><p><strong>Educational objective:</strong><br>Cirrhosis (ie, chronic liver disease) is responsible for &gt;80% of ascites.&nbsp; Splanchnic dilation due to portal hypertension is the underlying cause of ascites in cirrhosis.&nbsp; Other causes of portal hypertensive ascites include constrictive pericarditis and right-sided heart failure; nonportal hypertensive causes include nephrotic syndrome and peritoneal carcinomatosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 2802,
            "topic": "Ascites",
            "titleId": 2802,
            "title": "Ascites",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chronic liver disease",
                    "choiceNumber": 1,
                    "correctTaken": 10597,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Constrictive pericarditis",
                    "choiceNumber": 2,
                    "correctTaken": 237,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nephrotic syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 522,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ovarian cancer",
                    "choiceNumber": 4,
                    "correctTaken": 1156,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Right-sided heart failure",
                    "choiceNumber": 5,
                    "correctTaken": 1761,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1421,1516,true,-1,1*1539,1558,true,-1,1*1596,1627,true,-1,1*1671,1685,true,-1,1*1751,1971,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "410",
                    "mediaDataId": 0,
                    "title": "Cirrhosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 119,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 14273,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1855,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 2986,
            "questionIndex": 2986,
            "questionText": "<p>A 20-year-old college student is brought to the emergency department by his girlfriend after he ingested large amounts of acetaminophen in a suicide attempt.&nbsp; Two days ago, the girlfriend told the patient that she wanted to break up with him.&nbsp; He became distraught and took approximately 30 pills of 500-mg acetaminophen to end his life.&nbsp; This morning, the girlfriend discovered what he had done and brought him in to seek care.&nbsp; The patient reports nausea and mild abdominal pain.&nbsp; He has no history of previous suicide attempts or psychiatric illness.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 114/68 mm Hg, and pulse is 94/min.&nbsp; Abdominal examination reveals mild tender hepatomegaly.&nbsp; Serum acetaminophen level is high, and the patient is hospitalized for N-acetylcysteine therapy.&nbsp; During the hospital stay, he becomes markedly confused and incoherent.&nbsp; Repeat examination shows scleral icterus and asterixis.&nbsp; Current laboratory results and those obtained at the time of admission are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td></td><td><strong>At admission</strong></td><td><strong>Current</strong>&nbsp;</td></tr><tr><td colspan=\"3\">Liver function studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td>1.2 mg/dL</td><td>4.1 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase</td><td>96 U/L</td><td>8,456 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase</td><td>70 U/L</td><td>9,634 U/L</td></tr><tr><td colspan=\"3\"></td></tr><tr><td>Prothrombin time</td><td>18 sec</td><td>120 sec</td></tr><tr><td>Serum creatinine</td><td>1.1 mg/dL</td><td>3.5 mg/dL</td></tr></tbody></table><p>Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has <strong>acute liver failure (ALF)</strong> due to <strong>acetaminophen toxicity</strong>.&nbsp; ALF is defined as severe acute liver injury without underlying liver disease and is characterized by elevated aminotransferases (often &gt;1,000 U/L), <strong>hepatic encephalopathy</strong>, and <strong>synthetic liver dysfunction</strong> (defined as <strong>prolonged prothrombin time [PT]</strong> with INR <u>&gt;</u>1.5).&nbsp; Approximately only half of patients with ALF will survive without <strong>liver transplantation</strong>.&nbsp; Reliable indicators of worsening ALF include rising serum bilirubin and PT, as seen in this patient.&nbsp; Acute renal insufficiency, likely due to decreased renal perfusion, is common and portends a lower chance of recovery without liver transplantation.&nbsp; The degree of hepatic encephalopathy is also of prognostic importance as grade III hepatic encephalopathy (characterized by marked confusion and incoherence) is associated with an only 40%-50% chance of spontaneous recovery.&nbsp; <strong>Cerebral edema</strong> is a potential complication of ALF that may lead to coma and brain stem herniation, and is the most common cause of death.</p><p>The ethical considerations are complicated regarding liver transplantation for ALF due to a suicide attempt; however, in a patient with reactive depression and no history of psychiatric illness or previous suicide attempt, liver transplantation is typically pursued if needed.&nbsp; In ALF due to acetaminophen toxicity, liver transplantation is firmly indicated in patients with grade III or IV hepatic encephalopathy, PT &gt;100 seconds, and serum creatinine &gt;3.4 mg/dL (as in this patient).&nbsp; One-year survival following liver transplantation for ALF is approximately 80%.</p><p><strong>(Choices A and C)</strong>&nbsp; Liver biopsy is sometimes helpful in ALF of unclear etiology.&nbsp; This patient&#39;s ALF is due to acetaminophen toxicity and his condition is worsening.&nbsp; Close monitoring alone would not be appropriate, and liver biopsy is unlikely to prevent the need for liver transplantation.</p><p><strong>(Choice B)</strong>&nbsp; This patient&#39;s prolonged PT reflects coagulopathy due to ALF rather than due to vitamin K deficiency (often seen in patients with malnutrition).&nbsp; As a result, vitamin K supplementation will have limited effect on this patient&#39;s coagulopathy.</p><p><strong>(Choice E)</strong>&nbsp; Glucocorticoids are generally not indicated in ALF as they increase the risk of infection and have not demonstrated benefit in most etiologies of ALF.&nbsp; They may provide benefit in alcoholic hepatitis and in ALF due to autoimmune hepatitis.</p><p><strong>Educational objective:</strong><br>Survival without liver transplantation is low in patients with acute liver failure and indications that the disease is worsening or failing to improve.&nbsp; When appropriate, these patients should undergo early consideration for liver transplantation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 21090,
            "topic": "Acute liver failure",
            "titleId": 21090,
            "title": "Acute liver failure",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Close monitoring only",
                    "choiceNumber": 1,
                    "correctTaken": 2125,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Initiate vitamin K supplementation",
                    "choiceNumber": 2,
                    "correctTaken": 3132,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform liver biopsy",
                    "choiceNumber": 3,
                    "correctTaken": 519,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refer to liver transplant center",
                    "choiceNumber": 4,
                    "correctTaken": 8846,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start glucocorticoid",
                    "choiceNumber": 5,
                    "correctTaken": 1876,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "561,631,true,-1,1*784,869,true,-1,1*938,1075,true,-1,1*1353,1561,true,-1,1*2352,2440,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26421889",
                    "mediaDataId": 0,
                    "title": "Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26421889",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "17890263",
                    "mediaDataId": 0,
                    "title": "Fulminant hepatic failure: etiology and indications for liver transplantation.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/17890263",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16317692",
                    "mediaDataId": 0,
                    "title": "Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16317692",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 108,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 16498,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 997,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 15115,
            "questionIndex": 16539,
            "questionText": "<p>A 42-year-old man comes to the office for a routine medical evaluation.&nbsp; He has no known medical conditions but has not seen a health care provider in many years.&nbsp; The patient has had an intermittent, nonproductive cough and otherwise feels well.&nbsp; He takes no medications, drinks alcohol occasionally, and does not use tobacco or illicit drugs.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows no scleral icterus or mucosal pallor.&nbsp; The lungs are clear on auscultation and heart sounds are normal.&nbsp; The liver edge is palpable 3 cm below the right costal margin, and the spleen tip is palpable below the left costal margin.&nbsp; There is no skin rash or extremity edema.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>14.4 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>220,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>8,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" height=\"15\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>136 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>4.2 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>1.0 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td>11.2 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>100 mg/dL</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td>1.0 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td>370 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td>87 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td>74 U/L</td></tr></tbody></table><p>Chest x-ray shows mediastinal fullness and bilateral reticulonodular opacities, mostly involving the upper lungs.&nbsp; Which of the following is the most likely underlying cause of this patient&#39;s liver disease?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t50625\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Manifestations of sarcoidosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pulmonary</strong></p></td><td><ul><li>Hilar lymphadenopathy*</li><li>Interstitial infiltrates</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cutaneous</strong></p></td><td><ul><li>Papules, nodules &amp; plaques</li><li>Erythema nodosum*</li></ul></td></tr><tr><td><p align=\"center\"><strong>Ophthalmologic</strong></p></td><td><ul><li>Anterior &amp; posterior uveitis</li><li>Keratoconjunctivitis sicca</li></ul></td></tr><tr><td><p align=\"center\"><strong>Neurologic</strong></p></td><td><ul><li>Facial nerve palsy</li><li>Central diabetes insipidus</li><li>Hypogonadotropic hypogonadism</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cardiovascular</strong></p></td><td><ul><li>AV block</li><li>Dilated or restrictive cardiomyopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Gastrointestinal</strong></p></td><td><ul><li>Hepatosplenomegaly</li><li>Asymptomatic LFT abnormalities</li></ul></td></tr><tr><td><p align=\"center\"><strong>Other</strong></p></td><td><ul><li>Hypercalcemia</li><li>Peripheral lymphadenopathy</li><li>Parotid gland swelling</li><li>Polyarthritis*</li><li>Constitutional symptoms (fever,* malaise)</li></ul></td></tr><tr><td colspan=\"2\"><p>*Manifestations of L&ouml;fgren syndrome.</p><p><strong>AV</strong> = atrioventricular;<strong> LFT</strong> = liver function test.</p></td></tr></tbody></table></div><p>This relatively asymptomatic man has hepatosplenomegaly and liver function tests (LFTs) showing mixed cholestatic and hepatocellular abnormalities.&nbsp; Given his associated hypercalcemia and hilar lymphadenopathy (suggested by radiographic findings), this presentation is consistent with extrapulmonary <strong>sarcoidosis</strong>.</p><p>Sarcoidosis is a <strong>multisystemic</strong>, inflammatory <strong>granulomatous</strong> disease.&nbsp; Asymptomatic <strong>liver involvement</strong> (eg, abnormal LFTs, hepatomegaly) is common (~65%).&nbsp; Patchy infiltration by noncaseating granulomas can cause cholestatic (eg, mild alkaline phosphatase elevation) followed by hepatocellular (eg, mild aminotransferase elevations) changes.&nbsp; Reticuloendothelial granulomatous infiltration can also cause splenomegaly.</p><p>Other common sarcoidosis findings seen in this patient include <strong>lung</strong> involvement (&gt;90%), with <a href=\"22294\">radiographs</a> showing evidence of hilar lymphadenopathy (eg, described as upper lobe reticulonodular opacities, diffuse or nodular parenchymal infiltrates), and <strong>hypercalcemia</strong> (due to vitamin D conversion by macrophages in granulomas).</p><p>Biopsy of the most accessible lesion (eg, liver, enlarged lymph node) can establish the diagnosis.</p><p><strong>(Choice A)</strong>&nbsp; Excessive iron accumulation from hereditary hemochromatosis, which commonly affects middle-aged men, can cause infiltrative liver disease, resulting in hepatosplenomegaly and transaminase elevations (primary hepatocellular pattern).&nbsp; However, lung involvement and hypercalcemia would not be expected.</p><p><strong>(Choice B)</strong>&nbsp; Amyloidosis, a multisystem condition characterized by insoluble fibril deposition, can affect the liver, causing hepatomegaly and elevated alkaline phosphatase.&nbsp; However, this patient lacks other associated findings of amyloidosis, such as easy bruising and bleeding, peripheral edema (nephrotic syndrome), or anemia.&nbsp; In addition, hypercalcemia would not be expected.</p><p><strong>(Choice C)</strong>&nbsp; Hepatosplenomegaly and elevated alkaline phosphatase (primary cholestatic pattern) can be seen in patients with primary biliary cholangitis (PBC), a condition involving T-lymphocyte&ndash;mediated bile duct destruction.&nbsp; However, jaundice (eg, scleral icterus) is common, lung involvement is not seen, and &gt;90% of patients with PBC are women.</p><p><strong>(Choice D)</strong>&nbsp; Alpha-1 antitrypsin deficiency can cause early-onset lung emphysema, liver cirrhosis, and panniculitis.&nbsp; Elevated transaminases and cough can be presenting symptoms.&nbsp; However, chest imaging characteristically shows changes (eg, bullae) at lung bases, rather than the upper lobe opacities seen in this patient, LFTs typically show a primary hepatocellular pattern, and hypercalcemia would not be expected.</p><p><strong>Educational objective:</strong><br>Sarcoidosis is characterized by multisystem inflammatory noncaseating granuloma formation.&nbsp; Subclinical (asymptomatic) hepatic involvement is common, and liver function tests demonstrate a mixed cholestatic and hepatocellular pattern.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 13195,
            "topic": "Sarcoidosis",
            "titleId": 13195,
            "title": "Sarcoidosis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Excessive gastrointestinal iron absorption",
                    "choiceNumber": 1,
                    "correctTaken": 240,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Extracellular fibrillar protein deposition",
                    "choiceNumber": 2,
                    "correctTaken": 814,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Immune-mediated bile duct destruction",
                    "choiceNumber": 3,
                    "correctTaken": 802,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inherited alpha-1-antitrypsin deficiency",
                    "choiceNumber": 4,
                    "correctTaken": 4420,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic granulomatous inflammation",
                    "choiceNumber": 5,
                    "correctTaken": 10138,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "93,117,true,-1,1*274,330,true,-1,1*346,392,true,-1,1*410,459,true,-1,1*1140,1402,true,-1,1*1528,1649,true,-1,1*1654,1728,true,-1,1*2152,2521,true,-1,1*3049,3287,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22679408",
                    "mediaDataId": 0,
                    "title": "Hepatic sarcoidosis presenting as portal hypertension and liver cirrhosis: case report and review of the literature.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22679408",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "9186992",
                    "mediaDataId": 0,
                    "title": "Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/9186992",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18853979",
                    "mediaDataId": 0,
                    "title": "Gastrointestinal and hepatic manifestations of sarcoidosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18853979",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 169,
            "othersAvgTimeSpent": 89,
            "notes": null,
            "peopleTaken": 16414,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1006,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 14315,
            "questionIndex": 15723,
            "questionText": "<p>A 70-year-old man comes to the hospital due to worsening right upper quadrant pain, fever, and anorexia for the past 2 days.&nbsp; Today, he also developed chills.&nbsp; The patient was treated for acute diverticulitis 4 weeks ago.&nbsp; Medical conditions also include type 2 diabetes mellitus and hypertension.&nbsp; He does not use tobacco, alcohol, or illicit drugs.&nbsp; The patient has not traveled recently.&nbsp; Temperature is 39.3 C (102.7 F), blood pressure is 130/80 mm Hg, pulse is 98/min, and respirations are 18/min.&nbsp; Examination shows no jaundice.&nbsp; The right upper quadrant is markedly tender with some guarding on palpation.&nbsp; Bowel sounds are normal, and there is no ascites.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"width:193.5pt;\">Hemoglobin</td><td style=\"width:166.5pt;\">11.2 g/dL</td></tr><tr><td style=\"width:193.5pt;\">Leukocytes</td><td style=\"width:166.5pt;\">19,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"width:193.5pt;\">Total bilirubin</td><td style=\"width:166.5pt;\">1.7 mg/dL</td></tr><tr><td style=\"width:193.5pt;\">Aspartate aminotransferase (SGOT)</td><td style=\"width:166.5pt;\">90 U/L</td></tr><tr><td>Alanine aminotransferase (SGPT)</td><td>80 U/L</td></tr><tr><td>Alkaline phosphatase</td><td>190 U/L</td></tr></tbody></table><p>CT scan of the abdomen is shown in the exhibit:</p><p><img draggable=\"false\" id=\"4005\" src=\"https://www.uworld.com/media/U10111.png\" ></p><p>Blood cultures are obtained.&nbsp; Which of the following is the best next step in diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"1881\" src=\"https://www.uworld.com/media/L8698.png\" ></p><p>This patient with fever, right upper quadrant pain, leukocytosis, and elevated liver enzymes has a rounded, hypoattenuating lesion in the liver, which is concerning for <strong>pyogenic liver abscess</strong>.&nbsp; Pyogenic liver abscess can occur due to direct extension from biliary tract infections, penetrating trauma, or hematogenous spread from the systemic (eg, infectious endocarditis) or portal circulation (eg, intraabdominal infection).&nbsp; This patient likely developed the abscess as a result of his recent <strong>diverticulitis</strong>, which allowed for the spread of bacteria from the inflamed intestines through the portal circulation.</p><p>Manifestations typically include <strong>fever</strong>, <strong>right upper quadrant pain</strong> (which may be severe), <strong>leukocytosis</strong>, and <strong>elevated liver function studies</strong>.&nbsp; The diagnosis is confirmed with abdominal imaging; CT scan classically demonstrates a <strong>well-defined, hypoattenuating, rounded lesion</strong>, often surrounded by a peripherally enhancing abscess membrane.</p><p>Management includes blood cultures, antibiotics, and <strong>percutaneous aspiration</strong> and <strong>drainage</strong>, which is both diagnostic (eg, culture, Gram stain) and therapeutic; catheter placement is often required to drain large lesions.&nbsp; Surgical drainage can be considered for abscesses not amenable to percutaneous intervention.</p><p><strong>(Choice B)</strong>&nbsp; Malaria can present with fevers, anemia, and hyperbilirubinemia; however, it would not be expected to cause right upper quadrant pain or a hypoattenuating liver lesion on CT scan.&nbsp; It would also be unexpected in a patient who has not traveled recently.</p><p><strong>(Choice C)</strong>&nbsp; <em>Echinococcus granulosus</em> causes cystic liver lesions in individuals exposed to infected sheep or canines; patients are typically asymptomatic unless the cysts are large or rupture.&nbsp; Cysts are typically visible on a CT scan as thin-walled, septated lesions, occasionally with calcification.</p><p><strong>(Choices D and F)</strong>&nbsp; <em>Entamoeba histolytica</em> is a major cause of hepatic abscess; however, most patients with amebic liver abscess have a history of exposure in endemic areas (eg, India, Mexico).&nbsp; This diagnosis should be considered in patients without other, more common causes of abscess (unlike this patient with recent diverticulitis).&nbsp; Testing options include serology or stool analysis (eg, ova and parasite).</p><p><strong>(Choice E)</strong>&nbsp; This patient is at increased risk for <em>Clostridioides</em> (formerly <em>Clostridium</em>) <em>difficile</em> infection due to his recent hospitalization and antibiotic treatment for diverticulitis.&nbsp; However, <em>C difficile</em> infection is characterized by persistent, watery diarrhea and would not be expected to cause abscess formation.</p><p><strong>Educational objective:</strong><br>Pyogenic liver abscess typically presents with fevers, right upper quadrant pain, leukocytosis, and altered liver function tests.&nbsp; It can result from direct spread from the biliary tract or from hematogenous seeding of distal infection, particularly those involving the portal system (eg, diverticulitis).&nbsp; Diagnosis requires abdominal imaging, and management includes blood cultures, antibiotics, aspiration, and drainage.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 7510,
            "topic": "Liver abscess",
            "titleId": 7510,
            "title": "Liver abscess",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Percutaneous aspiration",
                    "choiceNumber": 1,
                    "correctTaken": 9667,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Peripheral smears for <em>Plasmodium</em> species",
                    "choiceNumber": 2,
                    "correctTaken": 275,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serology for <em>Echinococcus granulosus</em>",
                    "choiceNumber": 3,
                    "correctTaken": 2033,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serology for <em>Entamoeba histolytica</em>",
                    "choiceNumber": 4,
                    "correctTaken": 3207,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Stool test for <em>Clostridioides</em> (formerly <em>Clostridium</em>) <em>difficile</em> toxin",
                    "choiceNumber": 5,
                    "correctTaken": 789,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Stool test for ova and parasites",
                    "choiceNumber": 6,
                    "correctTaken": 1024,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "200,457,true,-1,1*460,645,true,-1,1*873,982,true,-1,1*1204,1296,true,-1,1*1651,1677,true,-1,1*1754,1862,true,-1,1*1997,2055,true,-1,1*2200,2274,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26656355",
                    "mediaDataId": 0,
                    "title": "Increased risk of pyogenic liver abscess among patients with colonic diverticular diseases: a nationwide cohort study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26656355",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 100,
            "othersAvgTimeSpent": 85,
            "notes": null,
            "peopleTaken": 16995,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 892,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 17238,
            "questionIndex": 18690,
            "questionText": "<p>A 42-year-old woman comes to the office for follow-up due to abnormal liver function studies.&nbsp; The patient reports no symptoms.&nbsp; Medical history is significant for primary hypertension, and she has been taking amlodipine for &gt;5 years.&nbsp; Family history is negative for liver disease.&nbsp; The patient drinks a glass of wine 3 or 4 times a week but denies smoking or illicit drug use.&nbsp; Temperature is 37.5 C (99.5 F), blood pressure is 146/80 mm Hg, and heart rate is 80/min.&nbsp; BMI is 28 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Scleral icterus and palmar erythema are absent.&nbsp; Cardiopulmonary and abdominal examinations are both unremarkable.&nbsp; Laboratory studies are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>13.8 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>390,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>6,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Total protein</td><td>11.2 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Albumin</td><td>4.2 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td>0.9 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td>90 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td>452 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td>512 U/L</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Coagulation studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;PT time</td><td>12 sec</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Activated PTT</td><td>29 sec</td></tr></tbody></table><p>Initial testing 3 months ago showed similar results.&nbsp; Which of the following most likely explains this patient&#39;s persistent laboratory abnormalities?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t58631\"><table class=\"table-default-style table-header-footer-style\" style=\"width:88.56%\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Autoimmune hepatitis</strong></p></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Presentation</strong></p></td><td><ul><li>Asymptomatic<ul style=\"list-style-type:circle;\"><li>Identified by abnormal liver function tests</li></ul></li><li>Symptomatic<ul style=\"list-style-type:circle;\"><li>Fatigue, anorexia, nausea, jaundice</li><li>Can progress to fulminant liver failure &amp;/or cirrhosis</li></ul></li><li>Often associated with other autoimmune disorders (eg,&nbsp;vitiligo, autoimmune thyroiditis, celiac disease)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br />findings</strong></p></td><td><ul><li>Hepatocellular pattern (&uarr;&uarr;&nbsp;AST &amp;&nbsp;ALT)</li><li>Hypergammaglobulinemia</li><li>Elevated autoantibodies<ul style=\"list-style-type:circle;\"><li>Anti&ndash;smooth muscle</li><li>Anti&ndash;liver/kidney microsomal type 1</li><li>Antinuclear (nonspecific)</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Histology</strong></p></td><td><ul><li>Portal and periportal lymphoplasmacytic infiltration</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Prednisone &plusmn;&nbsp;azathioprine</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALT</strong>&nbsp;=&nbsp;alanine aminotransferase; <strong>AST</strong>&nbsp;=&nbsp;aspartate aminotransferase.</p></td></tr></tbody></table></div><p>This woman with persistent asymptomatic elevations in aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and a large gamma gap (total protein &#8722; albumin = &gt;4 g/dL) has <strong>autoimmune hepatitis</strong> (AIH).&nbsp; AIH is thought to be triggered by environmental exposure in susceptible individuals; it occurs most commonly in <strong>women</strong> with comorbid autoimmune disease (eg, autoimmune thyroiditis, vitiligo).</p><p>The initial presentation is variable, with most patients presenting with constitutional symptoms (eg, fatigue, weight loss), abdominal pain, pruritus, and, possibly, cirrhosis (eg, jaundice, ascites).&nbsp; However, approximately 25%&nbsp;are <strong>asymptomatic</strong> and identified by routine blood work demonstrating&nbsp;a <strong>hepatocellular pattern</strong> of liver injury, with predominant <strong>elevations in AST and ALT</strong> and normal or mildly elevated alkaline phosphatase and bilirubin.&nbsp; High levels of autoantibodies (typically IgG) result in hypergammaglobulinemia and a <strong>gamma gap</strong>, a helpful characteristic feature (not seen in all cases).&nbsp; Positive serology (eg, anti&ndash;smooth muscle, anti&ndash;liver/kidney microsomal type 1, antinuclear antibodies) or hypergammaglobulinemia confirms the diagnosis.</p><p><strong>(Choice A)</strong>&nbsp; Alcoholic hepatitis also causes a hepatocellular pattern of injury, but an AST/ALT ratio of &gt;2:1 is expected, and transaminases rarely exceed 300 U/L.&nbsp; In addition, patients typically have heavy alcohol use (5 or 6 drinks/day), fever, and jaundice.&nbsp; A gamma gap would be atypical.</p><p><strong>(Choice B)</strong>&nbsp; Alpha1-antitrypsin deficiency (AATD) is an autosomal codominant condition leading to emphysema (typically presenting in patients in their 40s) and liver disease (eg, chronic hepatitis, cirrhosis).&nbsp; This patient does not have manifestations of emphysema (eg,&nbsp;cough, dyspnea) or a family history of liver disease, and a protein gap would not occur with AATD.</p><p><strong>(Choice D)</strong>&nbsp; Although amlodipine can cause hepatotoxicity, this adverse effect is exceedingly rare, typically develops within weeks to months (rather than after &gt;5 years), and is generally associated with a cholestatic pattern.&nbsp; An elevated gamma gap would not occur.</p><p><strong>(Choice E)</strong>&nbsp; Hepatitis A causes a hepatocellular pattern of injury, but it typically presents with vomiting, fever, and abdominal pain; transaminases are generally &gt;1,000 U/L and&nbsp;would be expected to normalize after 3 months.</p><p><strong>(Choice F)</strong>&nbsp; Primary biliary cholangitis is an autoimmune disorder characterized by elevated antimitochondrial antibodies.&nbsp; Although PBC can be asymptomatic and mild AST and ALT elevation can be seen, a cholestatic picture is expected, with marked elevations in alkaline phosphatase (&#8805;1.5x the upper limit of normal).</p><p><strong>Educational objective:</strong><br>Autoimmune hepatitis is characterized by a hepatocellular pattern of liver injury (elevations in aspartate aminotransferase and alanine aminotransferase with normal alkaline phosphatase and bilirubin), as well as high levels of autoantibodies, resulting in elevated serum globulins and a gamma gap.&nbsp; Positive serology (eg, anti&ndash;smooth muscle, anti&ndash;liver/kidney microsomal type1, antinuclear antibodies) or hypergammaglobulinemia confirms the diagnosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 1468,
            "topic": "Autoimmune hepatitis",
            "titleId": 1468,
            "title": "Autoimmune hepatitis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alcoholic hepatitis",
                    "choiceNumber": 1,
                    "correctTaken": 716,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Alpha-1-antitrypsin deficiency",
                    "choiceNumber": 2,
                    "correctTaken": 1403,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Autoimmune hepatitis",
                    "choiceNumber": 3,
                    "correctTaken": 9463,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Drug-induced liver injury",
                    "choiceNumber": 4,
                    "correctTaken": 3654,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatitis A",
                    "choiceNumber": 5,
                    "correctTaken": 826,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary biliary cholangitis",
                    "choiceNumber": 6,
                    "correctTaken": 1415,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2523,2560,true,-1,1*2904,2994,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26934884",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of autoimmune hepatitis: current status and future direction",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26934884",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 72,
            "othersAvgTimeSpent": 105,
            "notes": null,
            "peopleTaken": 17477,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 896,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 11358,
            "questionIndex": 12513,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td class=\"TableCellHighlight\" id=\"vignettedescriptor\">The following vignette applies to the next <strong>2</strong> items.&nbsp; The items in the set must be answered in sequential order.&nbsp; Once you click <strong>Proceed to Next Item</strong>, you will not be able to add or change an answer.</td></tr></tbody></table><p>A 54-year-old man comes to the office due to a 6-month history of fatigue, weakness, and intermittent nausea.&nbsp; The patient has no prior medical conditions and takes no medications.&nbsp; He has had prolonged and heavy alcohol use.&nbsp; There is no significant family history.&nbsp; Blood pressure is 116/74 mm Hg and pulse is 78/min.&nbsp; The patient is alert and oriented.&nbsp; He has significant muscle wasting and nontender enlargement of bilateral parotid glands.&nbsp; Multiple spider angiomas on the upper trunk and extremities are seen.&nbsp; Heart sounds are normal without murmur.&nbsp; Breath sounds are diminished at the right base.&nbsp; The abdomen is distended with shifting dullness.&nbsp; Rectal examination shows internal hemorrhoids, and stool is negative for occult blood.&nbsp; There is no tremor, and neurologic examination is normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Liver function studies</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"padding-left: 2em;\">Total bilirubin</td><td style=\"vertical-align:middle;\">2.1 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Alkaline phosphatase</td><td style=\"vertical-align:middle;\">130 U/L</td></tr><tr><td style=\"padding-left: 2em;\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">282 U/L</td></tr><tr><td style=\"padding-left: 2em;\">Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">120 U/L</td></tr><tr><td style=\"vertical-align:middle;\"></td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Complete blood count</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"padding-left: 2em;\">Hemoglobin</td><td style=\"vertical-align:middle;\">11.0 g/dL</td></tr><tr><td style=\"padding-left: 2em;\">Mean corpuscular volume</td><td style=\"vertical-align:middle;\">102 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em;\">Platelets</td><td style=\"vertical-align:middle;\">105,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em;\">Leukocytes</td><td style=\"vertical-align:middle;\">4,100/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\"></td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Coagulation studies</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"padding-left: 2em;\">INR</td><td style=\"vertical-align:middle;\">1.2</td></tr><tr><td style=\"padding-left: 2em;\">PTT</td><td style=\"vertical-align:middle;\">35 sec</td></tr><tr><td style=\"vertical-align:middle;\"></td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Hepatitis B surface antigen</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Hepatitis B core antibody</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Hepatitis C antibody</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>Abdominal ultrasonography reveals splenomegaly, ascites, and an echogenic, shrunken liver without any mass.&nbsp; After his clinical condition is discussed, the patient agrees to strictly follow medical recommendations.</p><p><strong>Item 1 of 2</strong></p><p>Which of the following studies is most appropriate for this patient at present?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"3269\" src=\"https://www.uworld.com/media/highresdefault/L25246.jpg\"  ></p><p>This patient with stigmata of chronic liver disease (eg, spider angiomas, muscle wasting), evidence of portal hypertension (eg, ascites, splenomegaly with thrombocytopenia), and abnormal liver function studies likely has <strong>cirrhosis</strong>.&nbsp; The etiology of cirrhosis in this patient can be attributed to prolonged, heavy <strong>alcohol use</strong>; additional supportive features include an aspartate aminotransferase to alanine aminotransferase ratio &#8805;2:1, macrocytosis, and parotid gland enlargement (eg, fatty infiltration).</p><p>If the initial clinical, laboratory, and radiologic evaluations strongly suggest an obvious etiology (eg, alcohol), further evaluation, including liver biopsy, for an underlying cause is not indicated <strong>(Choice C)</strong>.&nbsp; Management of patients with newly diagnosed cirrhosis includes identifying and treating reversible factors and <strong>potential complications</strong> (eg, variceal hemorrhage, hepatocellular carcinoma).&nbsp; <a href=\"3386\">Esophageal varices</a> are a major cause of morbidity and mortality that are commonly found in cirrhosis (due to portal hypertension).&nbsp; All patients with cirrhosis should undergo periodic <strong>upper endoscopy screening</strong> to exclude varices, determine the risk for variceal hemorrhage, and implement strategies to prevent bleeding (eg, initiation of a nonselective beta blocker).</p><p>Variceal hemorrhage is one of many clinical events that hallmarks decompensated cirrhosis; additional signs of decompensation include jaundice, ascites, and hepatic encephalopathy.</p><p><strong>(Choice A)</strong>&nbsp; Abdominal CT scan is not required at this time because this patient&#39;s ultrasonography did not reveal liver masses concerning for hepatocellular carcinoma (HCC).&nbsp; Abdominal ultrasonography should be repeated every 6 months for continued HCC screening (&plusmn; alpha-fetoprotein measurement).</p><p><strong>(Choice B)</strong>&nbsp; Although alpha-1 antitrypsin (AAT) deficiency can manifest as cirrhosis in this patient&#39;s age group, testing for AAT deficiency is not necessary because of the patient&#39;s history of heavy alcohol use that is clearly supported by laboratory evidence.</p><p><strong>(Choice D)</strong>&nbsp; Serum ammonia, which is often elevated in patients with hepatic encephalopathy (eg, asterixis, confusion), is not routinely checked in patients with cirrhosis.&nbsp; Moreover, the diagnosis of hepatic encephalopathy is typically made clinically without a serum ammonia level (ie, poor sensitivity and specificity).</p><p><strong>Educational objective:</strong><br>Patients with cirrhosis should undergo screening upper gastrointestinal endoscopy to exclude varices, determine the risk for variceal hemorrhage, and implement strategies to prevent bleeding (eg, initiation of a nonselective beta blocker).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 2874,
            "topic": "Cirrhosis",
            "titleId": 2874,
            "title": "Cirrhosis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 11358,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abdominal CT scan",
                    "choiceNumber": 1,
                    "correctTaken": 922,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Alpha-1 antitrypsin level",
                    "choiceNumber": 2,
                    "correctTaken": 107,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Liver biopsy",
                    "choiceNumber": 3,
                    "correctTaken": 553,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum ammonia level",
                    "choiceNumber": 4,
                    "correctTaken": 743,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Upper gastrointestinal endoscopy",
                    "choiceNumber": 5,
                    "correctTaken": 2846,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": "369,536,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "410",
                    "mediaDataId": 0,
                    "title": "Cirrhosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29551741",
                    "mediaDataId": 0,
                    "title": "Screening and surveillance of varices in patients with cirrhosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29551741",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 154,
            "othersAvgTimeSpent": 119,
            "notes": null,
            "peopleTaken": 5171,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 215,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 11359,
            "questionIndex": 12514,
            "questionText": "<p><strong>Item 2 of 2</strong><br>The patient is prescribed furosemide and spironolactone.&nbsp; Esophagogastroduodenoscopy reveals several medium-sized, nonbleeding, distal esophageal varices.&nbsp; Which of the following additional interventions is most appropriate at this time?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"7054\" src=\"https://www.uworld.com/media/highresdefault/L13534.jpg\"  ></p><p>This patient with medium-sized <strong>esophageal varices</strong> is at risk for spontaneous variceal <strong>bleeding</strong>.&nbsp; Patients with small varices that demonstrate bleeding risk factors or those with medium-sized or large esophageal varices should receive <strong>primary prophylaxis</strong> to prevent bleeding.</p><p>Primary prophylaxis can be achieved either with <strong>endoscopic variceal ligation</strong> (EVL) or daily administration of a <strong>nonselective beta blocker</strong> (nadolol, propranolol, carvedilol).&nbsp; Nadolol and propranolol significantly <strong>decrease portal pressure</strong> by promoting splanchnic vasoconstriction (by disrupting beta-2&ndash;mediated vasodilation) and lowering cardiac output.&nbsp; Carvedilol also blocks alpha-1 receptors within the hepatic sinusoids, further reducing intrahepatic resistance and portal pressure; however, its vasodilatory properties increase the risk for systemic hypotension.&nbsp; As such, carvedilol is typically used only in compensated cirrhosis (ie, no ascites, encephalopathy, jaundice), whereas <strong>nadolol</strong> and <strong>propranolol</strong> can be used in <strong>decompensated</strong> cirrhosis.</p><p>The choice of beta blocker or EVL depends on patient preference and the size of the varices; EVL is preferred for larger varices.</p><p><strong>(Choice A)</strong>&nbsp; Lactulose is used in patients with active hepatic encephalopathy (eg, asterixis, confusion) or a prior episode (ie, secondary prophylaxis).&nbsp; However, unlike variceal bleeding, hepatic encephalopathy does not typically require primary prophylaxis.</p><p><strong>(Choice B)</strong>&nbsp; Large-volume therapeutic paracentesis is typically reserved for patients with ascites resistant to diuretics.&nbsp; However, this patient was just prescribed furosemide and spironolactone and should first be assessed for diuretic responsiveness.</p><p><strong>(Choice C)</strong>&nbsp; ACE inhibitors (eg, lisinopril) have not been shown to reduce variceal bleeding.&nbsp; Moreover, they are typically avoided in cirrhosis due to the risk for hypotension (ie, blunts the renin-angiotensin-aldosterone system that helps maintain normotension).</p><p><strong>(Choice D)</strong>&nbsp; Cirrhosis without evidence of complications (eg, variceal hemorrhage, encephalopathy) is not a sufficient criterion for transplantation.</p><p><strong>(Choice F)</strong>&nbsp; A <a href=\"74325\">transjugular intrahepatic portosystemic shunt</a> is often used as salvage therapy in patients with refractory ascites or esophageal varices that have failed endoscopic or medical management.&nbsp; Hepatic encephalopathy is an expected consequence of this procedure.</p><p><strong>Educational objective:</strong><br>Nonselective beta blockers (eg, nadolol, carvedilol, propranolol) or endoscopic variceal ligation are the mainstays of primary prophylaxis for preventing esophageal variceal hemorrhage.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 6676,
            "topic": "Esophageal varices",
            "titleId": 6676,
            "title": "Esophageal varices",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 11358,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 1,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Lactulose",
                    "choiceNumber": 1,
                    "correctTaken": 190,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Large-volume paracentesis",
                    "choiceNumber": 2,
                    "correctTaken": 266,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lisinopril",
                    "choiceNumber": 3,
                    "correctTaken": 139,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Liver transplantation",
                    "choiceNumber": 4,
                    "correctTaken": 45,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nadolol",
                    "choiceNumber": 5,
                    "correctTaken": 4065,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transjugular intrahepatic portosystemic shunt",
                    "choiceNumber": 6,
                    "correctTaken": 633,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": "307,1058,true,-1,1*1153,1189,true,-1,1*2192,2386,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "410",
                    "mediaDataId": 0,
                    "title": "Cirrhosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "35355838",
                    "mediaDataId": 0,
                    "title": "Nonselective beta-blockers in portal hypertension: why, when, and how?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/35355838",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 16,
            "othersAvgTimeSpent": 28,
            "notes": null,
            "peopleTaken": 5338,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1149,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 18129,
            "questionIndex": 19593,
            "questionText": "<p>A 60-year-old woman comes to the office due to progressive fatigue over the past 6 months.&nbsp; She has no weight loss, joint pain, hematochezia, vomiting, dyspnea, cold intolerance, anxiety, or depression.&nbsp; Medical history is significant for hyperlipidemia, for which the patient has been taking simvastatin for 5 years.&nbsp; Family history is unremarkable.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 37.6 C (99.7 F), blood pressure is 142/80 mm Hg, pulse is 80/min, and respirations are 12/min.&nbsp; Sclera are anicteric and mucosal membranes are moist.&nbsp; Heart and lung sounds are unremarkable.&nbsp; The abdomen is nontender and nondistended.&nbsp; Hepatomegaly is present.&nbsp; Skin and musculoskeletal examinations are unremarkable.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">14.1 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">435,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">7,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Albumin</td><td style=\"vertical-align:middle;\">3.9 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td style=\"vertical-align:middle;\">0.7 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td style=\"vertical-align:middle;\">90 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">175 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">192 U/L</td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Blood, plasma, and serum</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Ferritin</td><td style=\"vertical-align:middle;\">1625 ng/mL</td></tr></tbody></table><p>Serology for viral hepatitis is negative.&nbsp; Right upper quadrant ultrasound reveals an enlarged liver with normal echotexture and no evidence of cirrhosis.&nbsp; This patient would most benefit from which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t61062\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hereditary hemochromatosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical manifestations</strong></p></td><td><ul><li>Hyperpigmentation</li><li>Arthropathy</li><li>Hepatomegaly, cirrhosis, hepatocellular carcinoma</li><li>Diabetes mellitus</li><li>Hypopituitarism, secondary hypogonadism</li><li>Cardiomyopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Elevated liver transaminases</li><li>Elevated serum ferritin, transferrin saturation</li><li><em>HFE</em> genetic mutations</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Therapeutic phlebotomy (urgent if ferritin &gt;1,000 ng/mL)</li></ul></td></tr></tbody></table></div><p>This patient has clinical features suggestive of <strong>hereditary hemochromatosis</strong> (HH), including hepatomegaly, <strong>elevated liver transaminases</strong>, and a striking elevation in <strong>serum ferritin</strong>.&nbsp; HH is an autosomal recessive disorder caused by an <em>HFE</em> genetic mutation and is characterized by increased intestinal iron absorption, tissue iron deposition, and ultimately multisystem end-organ damage.&nbsp; HH is most common in men and postmenopausal women; premenopausal women are less severely affected due to menstrual blood (and iron) loss.</p><p>Excessive iron stores in HH can be demonstrated by an elevated <strong>transferrin saturation</strong> (ie, serum iron/total iron binding capacity &times; 100).&nbsp; The diagnosis is confirmed by testing for <em>HFE</em> genetic mutations.</p><p>The treatment of choice is therapeutic phlebotomy, which helps keep ferritin levels low enough to avoid complications.&nbsp; Patients with <strong>extreme hyperferritinemia</strong> (eg, serum ferritin &gt;1000 ng/mL) must not wait for genetic testing results before receiving <strong>urgent phlebotomy</strong> because they are at exceptionally high risk for immediate and irreversible end-organ damage (eg, cardiomyopathy, cirrhosis, arthritis, diabetes).</p><p><strong>(Choice A)</strong>&nbsp; Statins (eg, simvastatin) can cause hepatotoxicity with elevated liver transaminases, but serum ferritin is not affected.&nbsp; Although this patient&#39;s statin may be suspended temporarily, either now or in the future if liver enzymes do not normalize, phlebotomy must be initiated immediately.</p><p><strong>(Choice B)</strong>&nbsp; Autoimmune hepatitis can be treated with prednisone.&nbsp; Although it can cause mild elevations in ferritin, levels typically do not exceed 1000 ng/mL.</p><p><strong>(Choice C)</strong>&nbsp; Penicillamine is used to treat Wilson disease.&nbsp; This inherited disorder can cause elevated liver enzymes, but clinical manifestations are generally apparent at age &lt;35, and most patients have neuropsychiatric symptoms (eg, psychosis, tremors).</p><p><strong>(Choice E)</strong>&nbsp; Patients with HH who are at low risk for end-organ damage (eg, ferritin &lt;500 ng/mL, normal liver function tests) may be closely followed with periodic laboratory testing; phlebotomy is initiated if laboratory values worsen or the patient develops symptoms of end-organ damage.</p><p><strong>(Choice F)</strong>&nbsp; Ursodeoxycholic acid is used to treat primary biliary cholangitis, which presents with fatigue and pruritis.&nbsp; Mild elevations in transaminases may occur, but profound alkaline phosphatase elevations and direct hyperbilirubinemia are more typical findings.</p><p><strong>Educational objective:</strong><br>Hereditary hemochromatosis is characterized by increased intestinal iron absorption, tissue iron deposition, and multisystem end-organ damage (eg, hepatotoxicity).&nbsp; The diagnosis is confirmed by testing for <em>HFE</em> genetic mutations, but patients with extreme hyperferritinemia (eg, serum ferritin &gt;1000 ng/mL) should receive urgent therapeutic phlebotomy without waiting for genetic testing results.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 16509,
            "topic": "Hemochromatosis",
            "titleId": 16509,
            "title": "Hemochromatosis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Discontinue simvastatin",
                    "choiceNumber": 1,
                    "correctTaken": 3030,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oral prednisone",
                    "choiceNumber": 2,
                    "correctTaken": 1177,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Penicillamine",
                    "choiceNumber": 3,
                    "correctTaken": 2502,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phlebotomy",
                    "choiceNumber": 4,
                    "correctTaken": 11568,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat blood tests in 1 year",
                    "choiceNumber": 5,
                    "correctTaken": 198,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ursodeoxycholic acid",
                    "choiceNumber": 6,
                    "correctTaken": 656,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "179,218,true,-1,1*297,320,true,-1,1*378,409,true,-1,1*997,1070,true,-1,1*1257,1553,true,-1,1*2219,2270,true,-1,1*2283,2559,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24054178",
                    "mediaDataId": 0,
                    "title": "Hereditary hemochromatosis: missed diagnosis or misdiagnosis?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24054178",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 98,
            "othersAvgTimeSpent": 89,
            "notes": null,
            "peopleTaken": 19131,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 785,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 4,
            "name": "CUSTOM"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}